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The discovery and use of antibiotics has had a huge impact on human, 
animal health, and agricultural production, but has come at the expense 
of the rapid rise of antibiotic resistant bacteria. In agriculture, patho-
genic bacteria do not only pose a problem for animals, but also for plant 
crops. There are three main measures to control plant diseases (1). First-
ly, one of the most practical and important methods to control diseases 
is the eradication, or prevention of inoculum. This can be achieved via 
quarantine, or eradication of contaminated plants (2), or destruction 
of contaminated seeds (1), as well as other methods that prevent the 
causal agent to infect a plant and cause a disease. In the second place, 
a very effective way of disease managing is the usage of genetically 
resistant plants. If resistant plants are available this can be a low cost 
measure of control (1). However, the process of developing resistant 
plants is slow and may take over a decade, additionally, the durability 
of the resistance is an important aspect and it can only be evaluated 
retrospectively (1). The third measure, that will be the focused of this 
review, is the chemical control of diseases with antimicrobial agents (1). 
This is usually the alternative adopted when a pathogen is present in a 
cropping area or in its neighborhood. This has proved to be an effective 
strategy to control plant diseases, especially when combined with the 
previous two methods (3).
Most antimicrobial compounds discovered so far are natural com-
pounds. The main strategy used to discover new antibiotics during the 
twentieth century was to screen for natural products with antimicro-
bial activity (4). However, there is an increasing concern of antibiotic 
resistance and speculations that the antibiotic pipeline is drying out 
(5, 6). Recently, the screens for natural products have been extended 
using new strategies with the use of improved cultivation methods and 
(meta-)genome-wide bioinformatics analyses. Nichols et al. (7) devel-
oped an isolation chip that allows to cultivate and isolate previously 
uncultivable organisms. This chip led to the discovery of Teixobactin (8). 
This compound is able to kill human pathogens such as Staphylococcus 
aureus and Mycobacterium tuberculosis and, so far, no resistance devel-
opment has been detected in a laboratory environment. Teixobactin 
kills Gram-positive bacteria by binding to the peptidoglycan precursors 
lipid II and lipid III, a mode of action different from any other antibiotic 
Abstract
The discovery and use of antibiotics has had a huge impact on human, 
animal health, and agricultural production, but has come at the ex-
pense of the rapid rise of antibiotic resistant bacteria. In agriculture, 
pathogenic bacteria do not only pose a problem for animals, but also 
for plant crops. Currently, few substances are available to treat plant 
infections, and those substances do not generally target specific bac-
teria. This limitation encourages farmers to use the same substances 
for extended periods of time and in higher concentrations, stimulating 
the development of resistance against these substances, resulting in 
their accumulation in the environment. During the course of evolu-
tion, plants, bacteria, and fungi have developed a massive arsenal of 
antibacterial compounds for their own defenses. Many of these com-
pounds have been shown to target bacterial cell division proteins and/
or disrupt the bacterial membrane. In this chapter, the use of some of 
these natural products and derivatives to control bacterial infections of 
plants will be discussed, using citrus canker, which impacts on global 














































seeds or the treatment of seeds with antibiotics such as streptomycin, 
kasugamycin, and oxytetracycline can reduce the disease caused by 
P. syringae (16–18). Induction of systemic acquired resistance is also 
a practice that can be used to control infections by P. syringae. In this 
case a compound induces the plant to produce an immune response that 
renders the plant resistant to the pathogen. Salicylic acid is a common 
inducer for systemic acquired resistance and can be used against P. 
syringae strains, including copper resistant ones (19, 20). 
 P. syringae pathovars phaseolicola and tomato were among the firsts 
organisms to have their virulence genes cloned, opening up the research 
in molecular biology of virulence over 30 years ago (21). 
2.2. Erwinia amylovora
Erwinia amylovora is the causal agent of fire blight, a disease that af-
fects pear, apple, quince and other rosaceous trees (22, 23). This dis-
ease was first reported in North America, already by the end of the of 
the 18th century (22, 24). About 100 years after its first description, 
the causative agent was identified as a bacterium, making Erwinia the 
first phytopathogen described (22, 24). Nevertheless, it was only fully 
sequenced in 2010 (25). During the 20th century fire blight spread to 
New Zeeland, Western Europe, and the Middle East. In areas where the 
pathogen has not been detected, such as Japan and Australia, quaran-
tine and eradication methods are used to prevent the introduction of 
the pathogen (24). In areas where the pathogen is endemic there are 
several approaches to control the disease.
Streptomycin, oxytetracycline, and copper are used in North America 
to prevent or reduce the disease in infected plants (26). However, those 
measures are faced with criticism since use of antibiotics contributes to 
the emergence of resistance against this compounds (26, 27). E. amylo-
vora infects blossoming trees, and managing the disease at this stage is 
crucial to prevent large amounts of inoculum spreading to other trees 
via bees or rain (28, 29). Once the bacteria are present in the blossom 
they can undergo up to 10 doublings a day in favorable temperature 
conditions. During the blossom blight phase sprays with streptomycin 
and oxytetracycline are most effective (28). At this stage the disease can 
also be managed through pruning of infected parts (28, 30). However, 
the pruning tools are also a vector via which the bacteria can spread, 
currently used to treat infections (8). Hover et al. (9) have developed a 
culture independent approach to prospect antimicrobial compounds, 
based on the hypothesis that the Asp-X-Asp-Gly calcium-binding mo-
tif is an indicative of bacterial encoded antibiotics with diverse mode 
of actions. Using degenerate PCR primers to amplify bacterial gene 
clusters encoding calcium binding motifs from environmental DNA, 
clusters were amplified, further identified and sequenced, and selected 
gene clusters were inserted in a host to express the genetic product 
(9). This approach led to the discovery of Malacidin A, which is active 
against Gram-positive organisms by binding to lipid II precursors in a 
calcium dependent manner (9).
Despite the recent discoveries of drugs targeting Gram-positive bacte-
ria, no new class of antibiotics against Gram-negatives has been identi-
fied since 1968, when quinolones were introduced (10). There have been 
trials to repurpose or to modify drugs in order to target Gram-negative 
bacteria, though none of them resulted in a viable antimicrobial yet (11, 
12). Drugs targeting gram negative bacteria are considered the highest 
priority for research according to the World Health Organization (13), 
and as will be discussed in the next section, the most important bacterial 
plant infections are caused by Gram-negative organisms, such as citrus 
canker, fire blight, bacterial speck of tomato, bacterial wilt of tobacco, 
and bacterial rice blight (14).
2. Important bacterial plant pathogens and control 
measures
2.1. Pseudomonas syringae
There are several Pseudomonas syringae pathovars, that combined are 
among the most important bacterial plant pathogens (14). With a few 
specific exceptions, such as kiwifruit, hazelnut and stone fruits, there 
are no economic data on crop loss caused by P. syringae (3). P. syringae 
species includes over 30 pathovars classified according to their different 
hosts, while P. syringae pv. syringae is often used to describe strains with 
a broader host range (15).
The three main measures to control plant diseases are applied in the 
control of P. syringae (3). Contaminated seeds are one of the main means 














































species and is a major threat to the orange industry (2). Xac causes 
citrus canker, and the most effective way to control the disease is to 
eradicate infected trees. However, since the pathogen can infect the 
trees before being detected and is very difficult to detect all infected 
trees in a given area (41), an effective eradication requires all the trees 
in a radius of 30 m from the infected tree to be eradicated as well, or 
the cutting of the entire block when the incidence of infection is over 
a 0.5 % (42). Despite being effective in keeping the incidence of citrus 
canker to less than 1 in 1 million trees in areas under threat (43); the 
eradication policy in the Brazilian state of São Paulo, the biggest orange 
producer in the world, led to the cut of 5.4 million between 1999 and 
2010, when a strict eradication policy was in effect (F. Behlau, personal 
communication).
Nowadays, citrus canker in São Paulo is managed by cutting only the 
symptomatic trees and spraying copper in a radius of at least 30 me-
ters of the infected plant (44). Similar measures were already used in 
Florida, Argentina and other Brazilian states where citrus canker is 
endemic and incidence levels are higher (45, 46).
therefore they should be dipped in bleach or ethanol solutions during 
the process (30).
Combining different methods in the management of the disease is 
also possible. Pseudomonas fluorescens strain A506 is available as an an-
tagonistic strain to help control fire blight, this strain is resistant against 
streptomycin and oxytetracycline and is able to reduce fire blight in-
fection when applied before E. amylovora is detected (31). Trees with 
limited sensitivity to the pathogen are available, but the commercial 
cultivation of those trees is limited by fruit quality and storability (32). 
2.3. Xanthomonads
The genus Xantohomonas includes species that infects nearly all major 
groups of higher plants. The economic importance of this disease varies 
from very destructive to negligible (33). The genus has a remarkable 
host diversity and a contrasting phenotypic uniformity, that have led to 
numerous discussions over the nomenclature of its members (34, 35). 
Here we will briefly mention some of the most important pathovars, 
and use Xanthomonas citri subsp. citri as a model for the remainder of 
this review. 
One of the most destructive pathogens in this genus is Xanthomonas 
oryzae pv. oryzae, the causal agent of bacterial blight of rice, one of the 
most important diseases of rice (36). Unlike E. amylovora and P. syringae, 
X. orizae pv. oryzae cannot be efficiently managed with copper or anti-
biotics (36). This is maybe because the pathogen is highly variable in 
terms of sensitivity to those compounds (36). Using resistant cultivars 
of rice has been the major method to manage the disease (36).
Xanthomonas axonopodis pv. manihotis is the causal agent of the bac-
terial blight of cassava, the staple food of nearly 600 million people 
(14, 37). This disease is mostly managed with inoculum prevention 
and eradication of contaminated crops (38). Resistant strains are also a 
possibility, and they are more effective when combined with culturing 
practices. When cassava is planted before a rainy season the conditions 
are more favorable to the pathogen. However, if the plants starts to grow 
in a dryer season, the growth is slower and plants accumulate more 
pectin and cellulose, and become more resistant to bacterial blight (37).
Xanthomonas citri subsp. citri (Xac), previously known as X. axonopodis 
pv. citri and X. campestris pv. citri (39, 40), can infect nearly all citrus 







































Against all these compounds, resistance has been reported, requiring 
that they are used in higher amounts with limited effectivity. Therefore, 
there is a need for new compounds to control bacterial plant diseases. 
One way to prevent bacterial species to infect plant hosts is to prevent 
them to undergo cell division, an essential process for bacterial prolif-
eration and viability. For this reason, we will review in the next section 
how the cell division machinery, the divisome, works and how it can 
be a target for novel antimicrobial compounds, using Xac as a model. 
3. The divisome and tools available for its study 
The divisome is the machinery required for cell division, consisting 
of many conserved proteins that share little to no homology with eu-
karyotic proteins and are essential for cell growth, multiplication, and 
pathogenicity (62). This makes cell division (proteins) a unique target 
for antimicrobials. Cell division has primarily been studied in Esche-
richia coli and Bacillus subtilis (63). However, due to the economic impor-
tance of Xac there have been recent efforts to further characterize the 
divisome in this organism (64–67), that had its genome fully sequenced 
16 years ago (68). In this section we will focus on the divisome from 
Xac. Recent advances made towards the understanding of the divisome 
of Xac have also resulted in tools that can be used to study the mode of 
action of antimicrobials. 
FtsZ is perhaps the most important piece in the cell division machin-
ery. Present in nearly all bacteria, this protein is a tubulin homologue 
GTPase that can polymerize to form the so-called Z-ring (63, 69). The 
Z-ring is a ring like structure, usually assembled at midcell, that con-
stricts the membrane to form 2 daughter cells (63). FtsZ consists of 
4 functional regions, a globular tubulin-like core, a C-terminal linker 
amino acid stretch, a conserved C-terminal tail region of 8 to 9 amino 
acids, followed by a C-terminal variable region of 4–10 amino acids 
(69, 70). The globular tubulin-like core contains the active site for GTP 
hydrolysis and is involved in the formation of dimers and higher or-
der polymers; the C-terminal tail is involved in the interaction with 
membrane associated proteins of the divisome, that are necessary to 
anchor the Z-ring in the plasma membrane, such as FtsA and ZipA; the 
C-terminal variable region mediates lateral interactions between FtsZ 
polymers; and the C-terminal linker serves as a link between the core 
Copper is the only antimicrobial agent used against Xac in most of 
areas of citriculture and its widespread use has led to the development 
of resistant strains in Argentina and the Reunion and Mauritius Islands, 
France (47, 48). This resistance is mostly plasmid borne, and plasmids 
can be transferred within different species of the same genus (46, 47), 
which is alarming considering that copper is probably the most com-
mon antimicrobial used in the field to control bacterial phytopathogens 
(Table 1). In addition, whereas antibiotics are inactivated in the soil 
(49), copper is stable and accumulates. High amounts of copper in the 
soil have a negative impact on bacterial richness and distribution in 
the soil (50).
In general, antimicrobial compounds currently used against bacterial 
phytopathogens are limited to copper, streptomycin, and oxytetracycline. 
Table 1: Bacterial pathogens, respective diseases, and available field antimicrobials.
Pathogen Disease (affected plants) Antimicrobial 
 compounds
X. citri subsp. Citri (Xac) Citrus Canker (orange, grapefruit and 
nearly all other citrus species (2))
Copper (46, 47)
Streptomycin (51)
X. oryzae pv. oryzae Bacterial blight (rice (36)) Not available1
Xanthomonas axonopodis 
pv. vesicatoria
Bacterial spot (tomato (20) and 
 pepper (52))
Copper (52)
P. syringae pv. syringae Bacterial leaf spot (green pumpkin 
(18))
Blossom blight (kiwifruit (53))
Apical necrosis (mango (54))





P. syringae pv. phaseo-
licola
Halo blight (common bean and nearly 




P. syringae pv. 
glycinea
Bacterial blight (soybean (57–59)) Not available1
P. syringae pv. 
tomato
Bacterial speck (tomato (20)) Copper 
Streptomycin (20, 60)
E. amylovora Fire blight (pear, apple, quince, 





Dickeya chrysanthemi Bacterial Leaf Blight (aglaonema (61)) Copper (61)
1To our knowledge there is no viable antimicrobial compound available to control this patho-







































In C. crescentus ParB acts as a chromosome partitioning protein, it 
colocalizes with the origin of replication at the cell pole (78). During 
a cell division event, the population of ParB splits and while one part 
remains static at one pole, the other part moves to the other cell pole 
together with the nucleoid of the future daughter cell (78). Divisome 
midcell positioning is mediated by MipZ, a protein that interacts with 
ParB and inhibits FtsZ activity, which avoids constriction over a nu-
cleoid and drives the Z-ring to midcell (78). Xac is somewhere ‘in the 
middle’ between E. coli and C. crescentus, as it both possesses a Min 
system composed of MinCDE, as well as ParB.
3.1. Chromosome segregation and the development of 
genetic tools in Xac
15 years ago, shortly after the genome was sequenced, open reading 
frames of Xac were expressed in E. coli for structural proteomic studies 
(79). A protocol for protein fingerprinting by 2-D gel electrophoresis 
and RNA expression assays was developed as well (67). The negative 
impact Xac causes on citrus economy stimulated further interest in 
studying Xac chromosome segregation and cell division, since they are 
nice targets for antimicrobials (80). Martins et al. (80) developed an 
expression system in Xac that lead to the characterization of FtsZ-stabi-
lizing factor ZapA, originally identified in B. subtilis (81). Xac zapA was 
fused with gfp and integrated in the α-amylase gene (amy) of Xac. The 
disruption of amy impaired Xac ability to degrade starch, but did not 
alter pathogenicity, making it possible to use this locus for other genetic 
integrations to study their effect on Xac biology and pathogenicity (80).
Ucci et al. (65) used this expression system to express an open reading 
frame encoding for a parB homologue in Xac, initially in amy under 
control of a xylose-inducible promoter. Later they investigated ParB 
function in Xac by expressing the fusion ParB-GFP under the control 
of its native promoter. They observed a polar localization of ParB-GFP, 
and time lapse fluorescent microscopy observations showed that the 
ParB-GFP signal splits and one of them moves to the other pole of the cell 
before cellular constriction, in an asymmetric manner. Simultaneous 
DNA staining with 4′,6-diamidino-2-phenylindole (DAPI, DNA binding 
fluorophore) revealed that ParB-GFP colocalizes with the edges of nu-
cleoids and is directly involved in chromosome segregation in Xac, in a 
domain and the membrane associated domain and is also essential for 
the coordination of cell wall synthesis at the division site (69, 71, 72). 
FtsZ from Xac shares over 96 % identity with FtsZ from X. campestris 
pv. campestris and X. oryzae pv. oryzae. The differences are in amino 
acids that constitute the C-terminal linker and amino acid changes in 
this domain of FtsZ do not cause functional alterations as long as the 
length remains unchanged (73). Therefore it is plausible that inhibitors 
of Xac FtsZ also inhibit FtsZ from other Xanthomonads.
In rod-shaped bacteria, the Z-ring is assembled at midcell, controlled 
by the so-called Min system. This machinery has been well studied in 
model organisms such as E. coli and B. subtilis, but was only recently 
studied in Xac (65). In E. coli, the Min system is composed of 3 proteins, 
MinC, MinD, and MinE (74). MinD is recruited to the membrane and 
forms copolymers with MinC inhibiting FtsZ activity (75). MinE forms 
an oscillating ring that disassembles MinCD copolymers, this dynamic 
process results in oscillation of the MinCD proteins with a higher con-
centration of MinCD at the cell poles as a net result. The relative absence 
of MinCD at midcell allows FtsZ to polymerize and assemble the Z-ring 
(75). In B. subtilis, MinE is absent and instead of a dynamic oscillation 
there is a static gradient of MinCD with again a higher concentration 
at the cell poles, mediated by DivIVA and MinJ proteins (75). Since both 
DivIVA and MinJ are absent in Xac, we are not going to discuss them 
in detail in this review.
The divisome is also linked with the chromosome segregation ma-
chinery, in order to avoid constriction over the nucleoid, which would 
result in DNA damage. This ensures that both daughter cells have the 
same genetic material. This phenomenon is called nucleoid occlusion 
and is mediated by different proteins in various bacteria, which bind to 
DNA and use different methods to prevent FtsZ polymerization in their 
vicinity (76). Interestingly, in E. coli, the min system also plays a role in 
chromosome segregation, because MinD binds to DNA and recruits it 
to the cell poles (77). However, this system seem to vary among species 
and Xac has a chromosome segregation factor absent in E. coli, called 
parB (65). The function of parB was already investigated in Caulobacter 
crescentus, an alphaproteobacteria that does not has a Min system and 








































potential inhibitory effect on cell division (11). Xac expressing GFP-Za-
pA exhibits a clear midcell localization that can be easily detected with 
fluorescent light microscopy, alterations in this localization pattern are 
an indication of cell division disruption. However, it is also important 
to point out that the subcellular localization pattern can be disrupted 
by membrane potential (90) or other artifacts (91) leading to false 
positives. Recently, the same strain has been used to study the effects 
of acetylated alkyl gallates (92) and other antimicrobials (Chapter 3) 
on Xac cell division.
3.2. Xac FtsZ as a target for antimicrobials
FtsZ is the most researched cell division protein as a target for anti-
microbials as inhibition of FtsZ would effectively block division (93). 
There is only one substance discovered so far that has been shown to 
inhibit cell division directly without interacting with FtsZ (94). Thus, 
nearly all cell division inhibitors can be characterized with FtsZ assays 
in vitro, and most reviews about cell division inhibitors focus largely 
on FtsZ inhibitors (95–97).
In Xac, the disruption of GFP-ZapA rings by various antimicrobials 
suggested that these compounds interfere with FtsZ function. Initially, 
the effect of alkyl gallates on cell division was further investigated with 
assays using the cell division protein FtsZ from B. subtilis (98). Alkyl 
gallates have antimicrobial activity against gram positives and selec-
tive activity on gram negatives, being ineffective against E. coli and 
Pseudomonas aeruginosa, but effective against Salmonella choleraesuis 
and Xac (11, 99). FtsZ from B. subtilis can be investigated in vitro using 
sedimentation, light scattering, and GTP hydrolysis assays (100). This 
way Król et al. (98) could show that FtsZ is a direct target of alkyl gal-
lates, that some of the alkyl gallates bind to FtsZ with high affinity and 
inhibit GTPase and polymerization activity. However, the alkyl gallates 
also have a membrane permeabilizing activity which could already 
disrupt subcellular localization of some cell division proteins (90, 98).
FtsZ from Xac is poorly characterized. To our knowledge, there has 
been one report on expression and purification of FtsZ from Xac, us-
ing a C-terminal his tag (101), and one report on FtsZ from X. oryzae 
pv. oryzae, also with C-terminal his tag (102). Activity of C-terminally 
his-tagged Xac FtsZ was only characterized using light scattering at 
similar manner exhibited by C. crescentus (65, 82). Although parB could 
not be deleted directly (65), a later study showed that it was possible 
to delete parB gene after introduction of a separate copy of parB under 
control of the arabinose promoter (83). Subsequent depletion of ParB 
revealed that the lack of parB caused a retardation in cell division, but 
there were no increase in filaments or anucleate cells, and the strain 
was still able to colonize citrus leaves (83). 
3.1.1. Xac Min system and cell wall synthesis
Xac possesses a full complement of the Min system, consisting of the 
MinCDE proteins. We have recently investigated this system by inacti-
vating out the minC gene and also expressing and visualizing GFP-MinC 
integrated in the amy locus of the genome (64). This showed that, as in 
other bacteria that contain MinE, MinC oscillates (64, 84). The deletion 
of minC did not disrupt the ability of Xac to infect citrus, but resulted 
in a branching phenotype depending on the growth medium used and 
most likely linked to gluconeogenic growth. Fluorescent D-amino acid 
analogues that label sites of peptidoglycan synthesis (85, 86), allowed 
us to further study the cell growth and branching of Xac. Xac exhibits 
a peptidoglycan incorporation pattern similar to the one observed for 
E. coli (64, 85), with strong synthesis at cell division sites, which was 
correlated with GFP-ZapA fluorescence. This correlation was lost when 
minC was deleted (64). 
3.1.2. Fluorescent reporters as tools to study Xac division 
inhibitors
The observations of subcellular localization of GFP fusions and/or flu-
orophores enables to not only expand the knowledge available about 
cell biology of organisms but also to use those tools to investigate the 
mode of action of antimicrobial compounds. The expression system 
developed by Martins et al. (80) was also used in the characterization of 
virulence genes in Xac (87). Liu et al. (88) inserted another expression 
system in Xac to express enhanced green fluorescent protein (EGFP) 
in order to visualize the propagation and localization of Xac in planta.
The Xac strain expressing GFP-ZapA was used as a reporter strain 
when investigating alkyl gallates, this compounds have been used 







































on β-lactamase at 30 µM. For all these molecules the inhibitory effect 
was attenuated in the presence of 0.1 % Triton X-100 (Tx100) (111). 
This means these compounds are not specific inhibitors of β-lactamase 
but rather cause the protein to aggregate, leading to a false positive 
result in a β-lactamase inhibition test (111). Feng & Shoichet (112) 
suggested the addition of 0.01 % Tx100 to detect false positives in 
screenings. The lower concentration of Tx100 is better tolerated by 
the enzyme, while it still counters protein aggregation. Anderson et al. 
(109) tested the effect of the addition of 0.01 % triton X-100 in FtsZ 
GTPase assays, in combination with the previously reported FtsZ in-
hibitors totarol (113), zantrin Z1 and zantrin Z3 (108), dichamanetin 
(114), and PC190723 (115). This showed that totarol, dichamanetin and 
zantrin Z1 no longer inhibited FtsZ GTPase activity in the presence of 
0.01 % triton X-100, indicating that the inhibitory effect is likely to be 
caused by the formation of aggregates (109). In fact, when when FtsZ 
incubated with totarol was previously centrifuged before the assay 
and supernatant was used, no activity was observed (109). Zantrin Z3 
inhibits GTPase activity of FtsZ and its activity was not changed in the 
presence of triton X-100 (109). PC190723 was reported to inhibit FtsZ 
GTPase activity, and that FtsZ is a target for PC190723 was evident from 
the fact that PC190723 resistant mutants exclusively mapped as point 
mutations in ftsZ (115). Anderson et al. (109) found no inhibition of 
PC190723 in Staphylococcus aureus FtsZ, but rather an increased GTPase 
activity caused by PC190723. An increase in GTPase activity caused 
by PC190723 was also observed by Elsen et al. (116).
We have purified native Xac and detected a consistent GTP turn-
over independent of Xac FtsZ concentration — which was striking as 
normally GTP hydrolysis only starts when the FtsZ concentration has 
reached a certain threshold. Both the malachite green and the coupled 
GTP regeneration assay work with Xac FtsZ. These assays allowed us 
to study the effect of alkyl-gallates on Xac FtsZ. Strikingly, the effect 
of these compounds was much less than what we previously observed 
with B. subtilis FtsZ.
3.3.2. Polymerization assays
Whereas GTPase activity is used as a proxy for polymerization, direct 
detection of polymers is possible using:
350 nm as a measure for polymerization (101), whereas X. oryzae FtsZ 
activity was only determined using a GTP hydrolysis assay (102). This, 
combined with the effects that buffers have on FtsZ behavior, makes 
it impossible to compare the results for these two FtsZs which share 
97 % sequence identity. Interestingly, Ha et al. (101) designed single 
stranded DNA aptamers with high binding affinity for Xac FtsZ. The 
aptamers showed a higher affinity for FtsZ from Xac than for FtsZ from 
B. anthracis, and they were able to inactivate 50 % of cells (MIC50) with 
about 115 µM (101). However, there are no data about whether those 
aptamers could prevent or treat Xac infections in planta, or whether 
they had selective antimicrobial activity in vivo (101).
In our lab we have purified native FtsZ from Xac (103). Below we 
discus methods to study FtsZ and their applicability to Xac FtsZ.
3.3. FtsZ assays in vitro and caveats
FtsZ activity can be measured by either monitoring GTP hydrolysis, 
which is linked to FtsZ polymerization, or by measuring FtsZ polymer-
ization and depolymerization (100, 104). Other assays done with FtsZ 
involve protein-protein interactions (100, 105). 
3.3.1. GTPase assay:
The GTPase activity of FtsZ was first detected using radiolabelled 
GTP (106, 107), which has since been replaced by a malachite green- 
phosphomolybdate assay, which provided an easier way to detect 
phosphate release as a measure of GTP hydrolysis (108). Various buffer 
conditions have been used for FtsZ GTPase measurements in the lit-
erature, which is important as buffer composition strongly influences 
FtsZ activity (98, 100, 106–109). The GTP hydrolysis can also be tested 
indirectly in an enzyme coupled assay using lactate dehydrogenase 
and pyruvate kinase (110). This system regenerates GTP from GDP 
while consuming NADH which is measured via absorbance at 340 nm 
(109, 110). This method reduces the effects of GTP depletion and GDP 
accumulation on the rate of reaction and enables an easy detection of 
GTPase activity (109, 110).
Compound-induced, aspecific, protein aggregation is a problem 
when screening for inhibitors. Feng et al. (111) randomly selected 







































methods are not useful when testing potential inhibitors of Xac FtsZ, 
but that GTP hydrolysis is reliable and quantitative.
3.3.3. Other FtsZ assays
There are other assays developed to study FtsZ, primarily by the Er-
ickson lab. Isothermal titration calorimetry has been used (125) to 
measure affinity parameters between FtsZ and the nucleotides. FtsZ, 
labeled with separate pools of fluorescein and tetramethylrhodamine, 
has been used to measure Förster resonance energy transfer (FRET) 
during FtsZ polymerization (126), which confirmed previous results 
that showed FtsZ cannot assemble below a critical concentration. In 
addition, a second critical concentration was observed, at which FtsZ 
can assemble in the absence of GTP (126).
3.4. Divisome inhibitors with targets other than FtsZ
Divin is the only antimicrobial substance so far identified that inhibits 
cell division directly without interacting with FtsZ (94). Divin chelates 
iron and downregulates the expression of cell division genes (127). 
This results in the affected cells to become arrested at a late stage of 
division, and similar results were obtained using other iron chelators 
(127). Divin did not alter chromosome function, ruling out the possi-
bility of indirect divisome inhibition, but also did not bind to or change 
the GTPase activity of FtsZ, but did cause dissociation of late division 
proteins in the divisome (94).
Research on cell biology and antimicrobials are complementary, and 
developments in one field contribute in the development of the other 
one. Divin is not only an antimicrobial but also a chemical probe to study 
cell division dynamics (94). It can be used to characterize new division 
proteins because it prevents association of late division proteins with-
out affecting early division proteins, its reversible bacteriostatic activity 
can be used to synchronize E. coli cells, and it can be used to observe 
FtsZ structures with cryo-electron microscopy (94).
3.5. Other potential divisome targets
FtsA is an essential protein in the E. coli (128) and Pseudomonas aeru-
ginosa (129), it is not essential in B. subtilis, but its deletion impaired 
growth and prevented sporulation (130). FtsA is also present in Xac, 
•  Sedimentation assays, where polymers (in a similar buffer system 
as used for the GTPase assay) are recovered by ultracentrifugation, 
and subsequently detected by SDS-PAGE (sodium dodecyl sulfate 
polyacrylamide gel electrophoresis) (100). Król et al. (98) showed 
that alkyl gallates stimulate B. subtilis FtsZ sedimentation and inhibit 
FtsZ GTPase activity.
•  Transmission electron microscopy (117, 118). Polymers can be for-
med under the same conditions used for sedimentation assay, fol-
lowed by negative staining with uranyl acetate and visualization 
(98, 117, 118). Electron microscopy enables the characterization of 
polymer shape and geometry, and the effect that regulatory proteins 
or antimicrobial substances might have on them, such as the bundling 
of polymers (98, 119, 120). Although many studies have been done 
with polymers formed in vitro, also in reconstituted vesicle systems, 
FtsZ polymerization in the cytoplasm cannot be observed with nega-
tive staining due to the crowded and granular nature of the cytoso-
lic environment (121). However, the development of cryo- electron 
tomography for imaging of structures in bacteria has allowed the 
visualization of FtsZ polymers in the Z-ring (122).
•  Light scattering, which is a convenient and nondestructive assay that 
enables the tracking of FtsZ polymerization and depolymerization 
in real time (100, 117, 123). FtsZ from E. coli readily polymerizes 
reaching a steady state phase proportional to the GTP concentration 
(123). In the presence of a GTP regeneration system like the one used 
for enzyme coupled GTPase assay, FtsZ polymers can remain stable 
for up to 85 min (124). Usually light scattering of FtsZ polymers is 
measured at a 90° angle in a fluorescence spectrophotometer with 
emission and excitation at 350 nm (100, 123).
None of these methods, however, is suitable for medium or high- 
throughput assays, but can render useful information on the nature 
of the polymers. We have tried all methods for Xac FtsZ and found that 
this protein has unique polymerization properties: Xac FtsZ already 
sediments when a divalent cation is added, independent of whether a 
nucleotide is used or not, and polymer detection using light scattering 
proved impossible (103). Detection of polymers by electron microscopy 
showed that Xac FTsZ forms short polymers that seem to bundle more 







































section, assays to detect other ways of inhibiting bacterial growth will 
be discussed. At the end of this section a flowchart for investigations on 
for investigations on the mode of action of antimicrobial compounds 
is presented Figure 3.
3.6.1. Macromolecular (DNA, RNA, cell wall and protein) 
synthesis pathway 
The majority of antibiotics affects either one of the 4 major macromo-
lecular synthesis pathways. A classical approach to establish inhibi-
tion of macromolecular synthesis is to incubate cells in the presence 
of the compound whose antimicrobial activity is meant to be tested 
and a radioactively labeled precursor (thymidine for DNA, uridine for 
RNA, glucosamine for cell wall or an amino acid such as leucine for 
protein) of each of the four metabolic pathways (140). After a growth 
period, during which the precursor can be incorporated in a respective 
macromolecule, cellular material is precipitated with trichloroacetic 
acid and quantified for radiation. The effect on the incorporation can 
be compared to cells incubated without compounds or with known 
inhibitors of each pathway.
This is perhaps the most widely used method throughout the an-
timicrobial discovery community (141). However, this test has a few 
drawbacks. This test is relatively slow, and it suffers from low reso-
lution, accuracy, and throughput. The test cannot identify different 
inhibitors that target different parts of the same metabolic pathway, 
and some compounds that rapidly inactivate cells such as nisin, bleach, 
and 7b-BF4 (Chapter 2) affect all the metabolic pathways will thus 
result in a non-specific output (141).
3.6.2. Membrane permeability
A few antibiotics that do not (directly) target the four macromolecular 
pathways mentioned above have action against the bacterial membrane, 
such as polymixins, paenibacterin, and daptomycin, which all create 
membrane pores (142–144). The formation of pores in the cytoplas-
mic membrane can be tested using two fluorescent DNA stains, one of 
which, SYTO 9, is membrane permeable, and one of which, propidium 
iodide, is membrane impermeable (probe of the ‘Live/dead Baclight via-
bility kit’). In case of pore formation the membrane becomes permeable 
but we do not know whether it is an essential protein. Moreover, FtsA 
is conserved among bacterial species and absent in eukaryotic cells, 
fulfilling an important feature of a potential target (129). Paradis- 
Bleau et al. (129) used phage display to develop peptides inhibiting 
FtsA activity, those peptides could inhibit 50 percent of ATPase activity, 
when used in concentrations from 0.7 mM. However, they showed no 
data about inhibition of cell growth in vivo (129). FtsA is an ATPase and 
this activity was detected in vitro using [γ-32P]-ATP and monitoring 
32phosphate release in a similar manner used for GTPase activity of 
FtsZ (131). This technique was already applied for FtsA from B. subtilis 
(131) and P. aeruginosa (129). 
The proteins of the complex FtsQBL are also an essential and import-
ant constituent of the divisome, and have been indicated as potential 
target for antimicrobials (97, 132). Those proteins are particularly at-
tractive as targets to block cell division because they have periplasmic 
domains, thus being exposed to inhibitors that does not necessarily 
need to penetrate through the inner membrane to be effective (133). In 
E. coli FtsB associates with FtsL and forms a complex that binds to FtsQ, 
consequently being recruited to the divisome (132). In B. subtilis the 
homologues of FtsQ and FtsB are named DivIB and DivIC respectively, 
and DivIC and FtsL are essential (134, 135). 
FtsN is another essential divisome protein considered a potential tar-
get for antimicrobials (97, 136). This protein is present in E. coli, Shigella 
spp., and Salmonella spp., and an inhibitor to this protein would prob-
ably be of narrow spectrum (97). Moreover, since this gene is absent 
in Pseudomonas spp. (97) and Xac, it cannot be considered a potential 
target for the development of field antimicrobials.
To our knowledge, no inhibitors that directly target FtsB, FtsQ, FtsL, 
or FtsN have been reported so far.
3.6. Assays to detect inhibitors with targets other than 
the divisome
A quick and easy assay to screen for cell division inhibitors is to look at 
cells using phase contrast microscopy — a cell division inhibitor will 
result in elongated, filamentous cells (11, 115, 137). However, cell elon-
gation can be induced by other antimicrobials such as the DNA synthesis 







































intracellular localization is lost and a diffuse structure can be seen 
(Figure 2). There are a number of other fluorescent fusion proteins 
expressed in B. subtilis to report different mode of actions, such as MinD, 
MinC, and FtsA that can report loss in membrane potential since their 
localization pattern is loss when the membrane potential is dissipated 
(90). The division site regulation protein DivIVA in B. subtilis exhibit a 
solid and clear localization pattern under most conditions, including 
the loss of membrane potential (90), and is a reporter for membrane 
fluidity alterations (150).
Another series of reporter B. subtilis strains are based on the fusion of 
the lacZ or firefly luciferase gene with promoters known to be expressed 
under specific antibiotic stress conditions (152–154). The expression 
of firefly luciferase gene generates a light signal in the presence of 
to propidium iodide which will stain the cell in red and also quench 
the SYTO 9 fluorescence reducing the green intensity, whereas imper-
meable cells are stained only by SYTO 9 exhibiting green signal (145).
3.6.3. Membrane potential
Some compounds, such as CCCP, do not form large pores in the mem-
brane but do dissipate the membrane potential by enabling the ex-
change of protons over the membrane. The membrane potential can 
be monitored using the fluorescent dye DiSC3 (3,3’dipropylthiadicar-
bocyanine iodide). This fluorophore inserts into polarized membranes 
upon which fluorescence is quenched. Loss of membrane potential 
results in the release of the dye from membranes and thus an increase 
in fluorescence (146).
3.6.4. Intracellular ATP concentration
In 2013, Bedaquiline, a new class of antibiotic, was approved after 
an almost 40 years gap in the discovery of drugs with a new mode of 
action (the last one was rifampicin, approved for use in 1974) (147). 
Bedaquiline targets ATP synthase in mycobacteria reducing intracellu-
lar ATP concentration leading to cell death (148). ATP can be measured 
using a bioluminescence assay measuring light output of the reaction 
between luciferin and ATP after cell lysis.
3.6.5. Use of reporter strains and morphological observations
There are a number of reporter strains that would indicate a specific 
effect targeting the bacterial cell. The strong aspect of this technique 
is the fact that strains submitted to the right conditions will report a 
specific mode of action happening on the cell. However, this method 
requires the access to a particular strain or cloning, and they will only 
yield an useful result if the mode of action is the same that the one the 
strain is designed to report.
The B. subtilis strain with a fluorescent fusion of the 30S ribosomal 
protein S2 (RpsB) can report the effect of both RNA and protein synthe-
sis inhibitors (149). Under ideal growth conditions RpsB localizes away 
from the nucleoids, protein synthesis inhibitors causes the nucleoids to 
compact, spreading the fluorescence signal from the cell pole further 
into the midcell, and when treated with a RNA synthesis inhibitor, 
Figure 2: subcellular localization of B. subtilis strain 1049 (151) expressing with RpsB-
GFP: A untreated, B treated with the RNA synthesis inhibitor 7b-BF4, C treated with the 
































caused by compounds such as nisin, bacitracin, or vancomycin (154). 
The yorB promoter is associated with DNA synthesis, yvgS with RNA 
synthesis, yheI with protein synthesis, ypuA with cell wall synthesis 
and cell envelope stress, and the fabHB promoter is associated with 
fatty acid synthesis (152). 
To tackle the necessity of constructing specific fluorescent protein 
fusions to make reporter strains for cytological profiling, Lamsa et al. 
(155) labelled cells with a combination of the membrane dye FM 4–64, 
the membrane permeable DNA dye DAPI, and the membrane imper-
meable DNA dye SYTOX Green. They observed the morphology of B. 
subtilis (155) and E. coli (141) cells in a fluorescence microscope in the 
presence of different antimicrobial compounds and it was possible to 
characterize specific changes in morphology depending on the mode 
of action of the compound. In a further study made a double blind test, 
with 30 known antimicrobial compounds, in which the tester was able 
to identify the mode of action of all the compounds by observing the 
morphological changes under fluorescent light microscopy, using a 
combination of the 3 dyes mentioned above (141).
4. Overview of thesis chapters
The focus of this thesis was initially intended to be a study on the mode 
of action and delivery of compounds developed to inhibit Xac and thus 
combat citrus canker. However, research in the field of mode of action 
of antimicrobials is often complimentary to cell biology research. New 
techniques developed to understand the function and behavior of mi-
crobial proteins can be used to study the mode of action of drugs, and 
compounds initially designed to be antimicrobials can be used to test 
the impact of new compounds under specific conditions. Therefore in 
this thesis we describe investigations on the mode of action of antimi-
crobial compounds as well as investigations on the cell biology of Xac, 
the causal agent of citrus canker. 
4.1. Chapter 2 — Discovery and investigations on the 
antimicrobial mode of action of the Au(I) compound 
7b-BF4
This chapter describes the screening for the gold liganded, and similar 
compounds, for antimicrobial activity. The most active of them, 7b-BF4, 
luciferin (152), and the expression of lacZ can be detected by measuring 
β-galactosidase activity (154) or by viewing a blue color in the presence 
of X-gal (153). The liaI promoter is a reporter for cell envelope stress 
























minC gene was complemented by integrating gfp-minC into the amy 
locus. Xac complemented strains displayed a wild-type phenotype. 
In addition, GFP-MinC oscillated from pole to pole, similar to MinCD 
oscillations observed in E. coli and more recently in Synechococcus elon-
gatus. Further investigation of the branching phenotype revealed that 
in branching cells nucleoid organization, divisome formation and pep-
tidoglycan incorporation were disrupted.
4.4. Chapter 5 — Concluding remarks
This chapter briefly recap the main findings and conclusions of each 
of the thesis chapters.
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was selected for investigations on the mode of action, using several tech-
niques described in this introduction. This compound is active against 
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The discovery of antibiotics, starting with penicillin in 1928, marked 
a revolution in biology and medicine, and ushered in the antibiotic 
era, in which mortality from a number of diseases drastically reduced, 
immediately increasing life expectancy worldwide (1). However, pen-
icillin resistance dramatically increased, shortly after its mass pro-
duction started (2), quickly becoming widespread. The introduction of 
β-lactams in the 1960’s tackled this problem, but again, shortly after its 
introduction, the first cases of beta-lactam resistance were reported (3). 
This was the first of several cycles of antibiotic resistance crises which 
have taken place over the last century (4, 5). The development of new 
classes of antibiotics has so far outpaced the spread of antibiotic resis-
tance (4). However, the continued discovery of new antibiotics is needed 
to avoid a widespread pandemic of antibiotic resistant bacteria (6).
The main strategy to discover antibiotics is to screen for microbial- 
derived natural products, in a similar way that lead to the discovery of 
penicillin (7). Another approach involves the screening of synthetic 
substances. The first synthetic substances found to have antibiotic ac-
tion, in modern medicine, were the sulfonamides in the 1930s, which 
were synthesized even before penicillin was used in a clinical setting (8). 
Once discovered and characterized for its mode of action, antimicrobial 
substances can be chemically modified to improve potency, stability, 
and pharmacokinetics. This strategy has resulted in dozens of new 
antibiotics being introduced in the clinics (8). However, it is generally 
accepted that substances belonging to classes that are completely new 
to the clinic are more effective in tackling resistance, when compared 
to more commonly used strategies (9).
Gold and other metal compounds have a long history in medicine (10), 
and are reported to have been used from ancient times throughout the 
late Middle Ages and the Renaissance (11). Currently gold compounds 
are used only for the treatment of rheumatoid arthritis (12). The antimi-
crobial activity of gold cyanide was already reported for the treatment 
of Mycobacterium tuberculosis (13). About 50 years ago platinum agents 
started to be used in the clinics to treat cancer (14). Interestingly, the 
inhibitory activity of platinum salts were discovered by mistake, when 
Rosenberg et al. in 1965 (15), were testing the effect of electric fields 
on Escherichia coli cell growth using platinum electrodes. Under those 
Abstract
Decades of antibiotic use to treat and prevent bacterial infections have 
led to a rapid increase in bacterial pathogens that are resistant to mul-
tiple antibiotics. Simultaneously, discovery and use of novel antibiotics 
has almost ground to a halt. Research is needed on known chemical 
scaffolds that were abandoned in the past. Gold compounds have a long 
tradition in medicine — eg as an anti-tubercular agent after Robert 
Koch discovered that gold effectively kills Mycobacteria. In this work 
we present investigations on the mode of action of the gold compound 
7b-BF4. This compound has antimicrobial activity and a potential as 
an antibiotic. We have tested its minimum inhibitory and bactericidal 
activities (MIC and MBC). 7b-BF4 is active against all Gram-positive 
bacteria tested, including Methicillin Resistant Staphylococcus aureus 
(MRSA) and Vancomycin Resistant Enterococcus faecium (VRE), in con-
centrations varying from 0.4 µg/mL to 3.4 µg/mL. To address the effect 
of the compound on macromolecular synthesis pathways we tested 
incorporation of radiolabeled precursors of DNA, RNA, protein, and 
cell wall in Bacillus subtilis. 7b-BF4 blocks DNA and protein synthesis, 
but also affects RNA and cell wall synthesis to a lesser extent. Further 
tests showed that 7b-BF4 doesn’t affect membrane permeability or mem-
brane potential. However, it causes a decrease in intracellular ATP and 





















































activity as a proton pump inhibitor (PPI) (18). However, PPIs are also 
useful to induce cisplatin sensitivity in human tumor cells, because they 
interfere with the micro-environmental acidity of tumors, a mecha-
nism of chemoresistance (19). Serratice et al. (11) synthesized gold(I) 
compounds featuring lansoprazole as a ligand, in order to combine the 
antiproliferative activity of gold with the PPI activity of lansoprazole. 
Those compounds were shown to have moderate activity against tumor 
cells (11).
In this work we screened the antimicrobial activity of a range of 
metal compounds, including the anticancer Ru(III) drug NAMI-A, the 
proton pump inhibitor lansoprazole, and the gold-based derivatives 
synthesized in the previous study (11) (Figure 1). One of these com-
pounds showed potent antimicrobial activity against Gram-positive 
bacteria and we investigated its antimicrobial mode of action by mon-
itoring DNA, RNA, protein and peptidoglycan synthesis, membrane 
integrity, and cellular energy levels in the presence of the compound. 
We also screened for the development of resistance against the com-
pound, but failed to produce resistant mutants.
2.  Methods
2.1. Minimal inhibitory and bactericidal concentration 
assays
The minimal inhibitory concentration (MIC) of compounds (Figure 1) 
was tested by broth microdilution. All compounds were tested against at 
least three strains (E. coli; Xanthomonas citri subsp. citri (Xac); Lactococcus 
lactis, Table 1), in case of compound 7b-BF4, the MIC was determined 
for all the strains listed in Table 1. Exponentially growing bacteria 
were diluted to OD600 of 0.005 in 96 well plates containing two-fold 
serial dilutions of the compounds, in a final volume of 200 µL of growth 
medium (Table 1). The MIC was defined as the lowest concentration of 
compound that prevented bacterial growth after incubating 24 hours 
at the indicated growth temperature (20). 
After 24 hours incubation approximately 2 µL of culture from each 
well was spotted onto agar plates composed of suitable growth medium. 
Plates were incubated overnight (or for 40 hours for Xac) at the indi-
cated temperatures. The minimum bactericidal concentration (MBC) 
conditions platinum salts were formed, which inhibited cell division 
and lead to cell filamentation (15). Following this discovery, Rosenberg 
and coworkers successfully hypothesized that the inhibitory effect of 
platinum compounds on cell growth was also effective against tumors 
(16), leading to the development of the most widely used cancer che-
motherapeutics nowadays (14). 
Another strategy less known for the discovery of antibiotics is the 
repurposing of known drugs that are already used in the clinic for 
a different purpose. This strategy was recently used to discover the 
antibiotic activity of lansoprazole against M. tuberculosis (17). Lanso-
prazole is a medicine currently used to treat peptic diseases due to its 
Figure 1: Structures of the compounds used in this study.
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tetracycline 10 μg/mL, peptidoglycan: vancomycin 1.0 μg/mL). At 
least four replicates were made per precursor tested. After incubation, 
samples were precipitated with ice-cold 12 % trichloroacetic acid for 
35 minutes and then filtered through nitrocellulose membranes (pore 
size 0.45 μm). The filters were washed with ice cold 12 % trichloroacetic 
acid, transferred to 2 mL scintillation fluid Ultima Gold MV (Perkin-
Elmer) and measured in a Tri-Carb 2000CA liquid scintillation analyzer 
(Packard Instruments).
2.3. HADA incorporation assay
Peptidoglycan synthesis activity was further monitored using the flu-
orescent D-amino acid analogue HADA (Hydroxycoumarin-carboxylic 
acid-Amino-D-Alanine), which is incorporated at sites of active pepti-
doglycan synthesis (25). Cells grown to early exponential phase were 
either incubated simultaneously with 7b-BF4 (at 0.43 or 1.72 µg/mL) 
and HADA (36.5 µg/mL) and grown for 35 minutes, or cells were grown 
for 30 minutes with 7b-BF4 followed by a 5 minutes pulse with HADA. 
HADA labelling for 5 minutes in the presence of Vancomycin (2 µg/mL) 
was used as a control.
After each treatment the cells were washed twice with Hanks’ Bal-
anced Salt Solution (KCl 0.40 g/L, KH2PO4 60 mg/L, NaCl 8.0 g/L,  NaHCO3 
0.35 g/L, Na2HPO4 48 mg/L) and visually inspected using a Nikon Ti-E 
microscope (Nikon Instruments, Tokyo, Japan) equipped with a Ham-
amatsu Orca Flash 4.0 camera. 
2.4. Killing dynamics
Freshly inoculated cultures of B. subtilis or S. aureus were grown to 
OD600 of about 0.15, equivalent to approximately 2 × 107 or 6 × 107 colony 
forming units (CFU), respectively. At this moment the cultures were 
split in 1 mL test tubes with 4 times the MIC of 7b-BF4, together with 
controls without compound. Aliquots were taken after 0.75, 1.5, 3, 6, 
and 24 hours. The amount of CFU/mL in each sample was determined 
by seeding serial dilutions of aliquots on LB or CAMH agar plates which 
were incubated at 30 °C for 20 h.
To observe the effect of 7b-BF4 in real time, a freshly grown culture of 
B. subtilis was diluted to OD600 of 0.005 in a 96-well plate. The plate was 
incubated in a microplate spectrophotometer (1000 rpm; 30 °C). When 
was defined as the lowest concentration of compound that prevented 
visible cell growth on compound-free agar plates.
2.2. Macromolecular synthesis 
Four macromolecular synthesis pathways were evaluated by monitoring 
the incorporation of radioactively labelled precursors. [53H]uridine, 
[methyl3H]thymidine, L[3,4,53H(N)]leucine and D[63H(N)]glucosamine 
hydrochloride (all at 0.5 µCi/mL) were used to respectively monitor 
RNA, DNA, protein and peptidoglycan synthesis. During this experi-
ment B. subtilis cells were grown to early exponential phase in modified 
Davis Minimal Medium: casamino acids 2.0 g/L; K2HPO4 7.0 g/L; KH2PO4 
3.0 g/L; MgSO47(H2O) 0.1 g/L; (NH4)2SO4 1.0 g/L; tri- Sodium citrate 
dihydrate 0.5 g/L; glucose 7.0 g/L and tryptophan 10 mg/L modified 
from (23, 24). Non-labelled precursor (1 mM) was used for RNA and 
peptidoglycan and 10 µM was used for DNA and protein. 
Cells were incubated in the presence of labelled precursors for 
80 minutes with shaking at 30 °C, in the presence of 0.43 µg/mL (312 nM) 
7b-BF4, without compound (negative control) or with an antibiotic 
known to inhibit the synthesis pathway tested as positive control (RNA: 
rifampicin 0.625 µg/mL, DNA: ciprofloxacin 0.625 μg/mL, protein: 
Table 1: list of strains tested with 7b-BF4 and growth conditions.
Origin Strains Growth medium (temperature)
Laboratory Escherichia coli MG1655 LB-Lennox (30 °C)
Bacillus subtilis 168 LB-Lennox (30 °C)
Lactococcus lactis MG1363 M17 (with 0.5 % glucose) (30 °C)
Xanthomonas citri subsp. citri (Xac) (21, 22) NYGB (30 °C)
Clinical Staphylococcus aureus UMCG #333 CAMH (35 °C)
Methicillin resistant Staphylococcus aureus 
D22 (MRSA)
CAMH (35 °C)
Enterococcus faecium VanA (VRE) TSB (35 °C)
Enterococcus faecium TSB (35 °C)
Media composition per liter: LB-Lennox, 10 g tryptone, 5 g yeast extract, 5 g NaCl. M17, 5.0 g 
glucose, 5.0 g pancreatic digest of casein, 5.0 g soy peptone, 5.0 g beef extract, 2.5 g yeast extract, 
0.5 g ascorbic acid, 0.25 g MgSO4, 19.0 g disodium-β-glycerophosphate. NYGB, 20 g glycerol, 5 g 
peptone, 3 g yeast extract. CAMH, 20 g NaCl, 17.5 g casein acid hydrolysate, 3.0 g beef extract, 
1.5 g starch, 25 mg CaCl2, 12.5 mg MgCl2. TSB, 17.0 g casein peptone (pancreatic), 5.0 g NaCl, 







































































0.21, 0.43, 0.86, and 1.72. The cells were incubated in a 96 well plate 
for 5 and 30 min (26 °C, 1000 rpm) after which 100 µL of cell culture 
was added to 100 µL of BacTiter-Glo™ Reagent for 5 minutes in a white 
96 well plate (26 °C, 1000 rpm). Luminescence was measured in a Tecan 
Infinite F200 Pro luminometer. The amount of light emitted is a measure 
for the intracellular ATP concentration.
2.8. Subcellular localization of fluorescent proteins in 
B. subtilis
We used the strains listed in Table 2 expressing a range of different 
fluorescent protein fusions that are related to specific cellular processes, 
to study the effect of 7b-BF4 in those processes. 
Fresh cultures were prepared by diluting overnight cultures and 
inducing them for about 4 hours with the respective inducer (Table 2) 
when needed. After that, cells were treated with 1.72 µg/mL 7b-BF4, 
or different controls depending on the marker observed, rifampicin 
(0.625 µg/mL) was used for RpoC fusion, tetracycline (10 μg/mL) was 
used for RpsB fusion and nisin (1.5 µg/mL) was used for all the other 
OD600 reached 0.2, 7b-BF4 was added at different concentrations. The 
OD600 was recorded for an additional 1.5 hours, after which the viability 
of the samples was determined by CFU counting as described above.
2.5. Membrane permeability assay
Membrane integrity was assessed using the commercial Live/Dead 
BacLight bacterial viability kit (Invitrogen) for microscopy as described 
by (26), with some modifications. Cells were incubated for 15 min at 
30 °C in the presence of 7b-BF4 (at 0.43 or 1.72 µg/mL), nisin (5 µg/mL, 
control) or without drug added. The dyes propidium iodide (14 µM) and 
SYTO 9 (2.4 µM) were used to stain the DNA of cells. After incubation, 
cells were mounted on agarose pads and analyzed using a Nikon Ti-E 
microscope (Nikon Instruments, Tokyo, Japan) equipped with a Ham-
amatsu Orca Flash 4.0 camera. Phase contrast, as well as green (FITC 
filter) and red (TRITC filter) fluorescence, were imaged. 
2.6. Membrane potential
Membrane depolarization was measured in B. subtilis hyperpolarized 
cells with the membrane potential dye DiSC3 (27) in a protocol adapted 
from (28, 29). Valinomycin was used to disrupt the sodium gradient 
and nisin was used as a control. B. subtilis cells were grown to OD600 of 
0.6. Then, they were diluted 2-fold in PIPES buffer with DiSC3 (6 µM) 
and 194 µL aliquots were dispensed in a 96 well microplate. After sta-
bilization of the fluorescence signal (5 minutes), valinomycin (0.2 µM) 
was added. After the fluorescence signal had again stabilized (8 min-
utes), nisin (1.5 µg/mL) or different concentrations of 7b-BF4 (varying 
2 fold from 0.215 to 13.7 µg/mL) were added to the cells in the 96 well 
microplate (200 µL final volume). The experiment was carried out in 
a BioTek Synergy Mx 96-well plate reader. Fluorescence (excitation: 
643 nm; emission: 666 nm; 9 nm bandwidth) was recorded every minute 
for 30 minutes after the addition of 7b-BF4 or nisin.
2.7. ATP assay
ATP levels were measured in B. subtilis using the BacTiter-Glo™ Micro-
bial Cell Viability Assay (Promega). CCCP (Carbonyl cyanide m-chloro-
phenyl hydrazine, 20 µg/mL) and lansoprazole (8.8 µg/mL) were used as 
controls, 7b-BF4 was used in the following concentrations (in µg/mL): 
Table 2: B. subtilis strains used for subcellular localization in this study.
Strain Marker Function Inducer Genotype Reference
TB35 MinD Division site 
regulation
0.1 % xylose amy::spc Pxyl-gfp-minD (30)
1803 DivIVA 0.5 % xylose divIVA::gfp‐divIVA Cm (31)
PG62 FtsA Cell division 0.1 mM IPTG aprE::spc Pspac‐yfp‐ftsA (32)
4056 FtsZ 0.1 % xylose amyE::spec Pxyl-gfp-pmutl-ftsZ (30)
1049 RpsB DNA, RNA, 
 Protein 
synthesis
0.1 % xylose trpC2 amyE::(spc Pxyl-rpsB-gfp) (33)
1048 RpoC 0.5 % xylose trpC2 chr::pST3 
(rpoC-gfpa cat Pxyl-′rpoC)
(33)




MW10 MreB Cytoskeleton 0.1 % xylose amyE::spc Pxyl‐gfp‐mreB (30)
3416
MreD
0.3 % xylose cat mreC::Pxyl‐gfp‐mreD (34)
3417 MreC 0.3 % xylose cat mreC::Pxyl‐gfp‐mreC (34)
HM160 Spo0J Chromosome 
segregation
- kan spo0J‐gfp (35)





















































and VRE was identical to the MIC and MBC for their respective drug 
sensitive analogues (Table 4), indicating that the resistance mecha-
nisms of these strains do not provide protection against 7b-BF4.
strains. After 5 to 40 minutes of incubation in contact with the com-
pounds the cells were added to agarose pads and imaged using a Nikon 
Ti-E microscope (Nikon Instruments, Tokyo, Japan) equipped with a 
Hamamatsu Orca Flash 4.0 camera.
2.9. Single step resistance
The potential incidence of single step resistance was determined using 
B. subtilis. Cells were grown to early exponential phase and approxi-
mately 2 × 109 CFU were spotted onto LB agar plates with 6.25 µM and 
15.6 µM ML4. The plates were stored at 30 °C for 4 days, and were in-
spected every day to check for bacterial growth.
3. Results
3.1. Screening Gold-liganded compounds for 
antimicrobial activity
To identify potential antimicrobials we tested 16 compounds (Figure 1) 
initially synthesized for anticancer activity (11). The screen included 
two Gram-negative (Xac, E. coli) and one Gram-positive bacterial species 
(L. lactis). The majority of compounds showed no or only mild activi-
ty against the panel strains (Table 3). The compound 7b-BF4 however, 
showed strong antibacterial activity against the Gram-positive reference 
strain (Table 3). A MIC in the sub µg/ml range is indicative of the poten-
tial to serve as an antimicrobial. Due to this result we decided to further 
investigate the antibacterial activity and mode of action of this compound.
3.2. 7b-BF4 shows selective activity against Gram-positive 
bacteria
First, we wanted to establish whether 7b-BF4 showed potent antibacte-
rial activity against other Gram-positive organisms, including clinical 
isolates of antibiotic-resistant pathogens like Methicillin Resistant S. 
aureus (MRSA) and Vancomycin Resistant E. faecium (VRE). Indeed, 
7b-BF4 killed all Gram-positive bacteria tested, and the concentration 
required to kill cells (MBC) was the same required to inhibit growth 
(MIC, Table 4). This result indicates that 7b-BF4 is a bactericidal rather 
than a bacteriostatic agent, as the inhibition of bacterial cell growth 
seems to be irreversible (36). The MIC and MBC determined for MRSA 
Table 3: Minimal inhibitory and bactericidal concentrations of the compounds tested 
(values displayed in µg/mL).
Xac E. coli L. lactis
Drug MIC MBC MIC MBC MIC MBC
FC19–837A >98 >98 >98 >98 >98 >98
MT03–130 >79 >79 >79 >79 >79 >79
2a 30.0 30.0 240 >240 3.75 7.5
AuOXO1 10.3 20.6 10.3 41 82 82
NAMI-A 146 146 >146 >146 >146 >146
VMePhen 18.9 >151 75.4 >151 >151 >151
AuMPO 5.9 46.8 46.8 >374 46.8 374
Au[bipy2OMe] 6.29 12.6 >25.2 >25.2 6.29 12.6
7b-BF4 >55 >55 >55 >55 0.43 0.86
1a >46.9 >46.9 46.9 46.9 >23.4 >23.4
HL1 >29.5 >29.5 >29.5 >29.5 >14.8 >14.8
HL2 >28.3 >28.3 >28.3 >28.3 >14.2 >14.2
Na-3a >161 >161 40.2 40.2 40.2 80.4
2b-BF4 >73.2 >73.2 >73.2 >73.2 18.2 36.5
5b 28.9 28.9 28.9 28.9 28.9 28.9
8 >115 >115 >115 >115 14.4 57.6
Table 4: MIC and MBC of 7b-BF4 (values displayed in µg/mL).
Organism MIC (µg/mL) MBC (µg/mL)
B. subtilis 0.43 0.43
L. lactis 0.43 0.86
S. aureus 3.44 3.44
MRSA 3.41 3.44
E. faecium 0.86 0.86
VRE 0.86 0.86
Xac >55 >55






























































(40). We showed inactivation curves for up to about 99.9 % reduction, 
as this is considered the endpoint defining the complete eradication of 
an organism (41, 42) as a complete eradication is not readily achiev-
able (43). However, we observed that S. aureus cells after 24 hours 
were completely inactive and we were unable to spot colonies in agar 
plates even when plating the equivalent of 105 CFU cells treated with 
compound.
3.4. 7b-BF4 affects the four major macromolecular 
synthesis pathways
To investigate whether 7b-BF4 targets the synthesis of specific, essen-
tial, macromolecules, cells were grown for 80 minutes, either with or 
without 7b-BF4, in the presence of radiolabeled precursors of macro-
molecule pathways (DNA, RNA, protein and peptidoglycan). 7b-BF4 
caused a sharp decrease in protein (leucine) and DNA (thymidine) 
synthesis (Figure 4). However, RNA (uridine) and peptidoglycan syn-
thesis (glucosamine) were also affected (Figure 4). Although endpoint 
results are presented, in the case of RNA and peptidoglycan synthesis 
the incorporation of precursors was linear over time, and inhibition 
was proportional over the time curve, indicating that the inhibition is 
constant (not shown). These results indicate that 7b-BF4 does not target 
one specific macromolecular synthesis pathway. 
3.3. 7b-BF4 rapidly kills B. subtilis and S. aureus cells
After establishing that 7b-BF4 is able to inhibit growth of Gram- positive 
organisms we decided to test how fast this inhibition and potential 
inactivation happens. B. subtilis cells are inhibited as early as 5 minutes 
after addition of 7b-BF4 to a growing culture (Figure 2), and 99.9 % of 
B. subtilis cells were killed after the treatment with 4 × MIC concentra-
tion (Figure 2).
To test the dynamics of the inactivation we exposed about 107 CFU/mL 
of growing cultures of B. subtilis or S. aureus to lethal concentrations 
(4 × MIC) of the compound for different periods of time. We observed 
that 99.9 % of the B. subtilis population was killed between 90 and 
180 minutes when exposed to 1.72 µg/mL of 7b-BF4, Figure 3A. The 
population of S. aureus was 99.9 % inactivated after 180 minutes in the 
presence of 13.8 µg/mL (4 × MIC) of 7b-BF4, Figure 3B. 
This rate of killing of S. aureus is faster than rates reported for 
closthioamide (37), kendomycin (38), vancomycin (39), teixobactin 
(39), or rifampicin (40); and similar to levofloxacin, gentamicin, and 
daptomycin when used at 10 times MIC concentration in S. aureus 
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Figure 2: Short term effect of 7b-BF4 on cell viability in B. subtilis. Lines are the median 
and shades are the standard error of 4 replicates.
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Figure 3: CFU assay in (A) B. subtilis and (B) S. aureus cells untreated or treated with 






























































B. subtilis cells (Figure 5A, B). Cells that were previously treated with 
7b-BF4 for 30 minutes prior to HADA labelling showed no incorporation 
of HADA. At an increased concentration of 7b-BF4 (1.72 µg/mL), there 
was no detectable HADA incorporation, even if the incubation period 
with 7b-BF4 was short. This was similar manner to what was observed 
for the peptidoglycan synthesis inhibitor vancomycin (Figure 5C, D).
These results indicate that HADA incorporation can be used as a fast 
and less laborious alternative to the classic radioactive glucosamine 
incorporation assay to detect inhibition of peptidoglycan synthesis.
3.5. 7b-BF4 affects HADA incorporation
In B. subtilis, the D-amino acid analogue HADA is incorporated at the 5th 
position of the pentapeptide of the peptidoglycan subunit, and can be 
used to show sites of peptidoglycan synthesis activity (25). To corrob-
orate the results obtained with D[63H(N)]glucosamine hydrochloride, 
we used HADA labelling as a second test for peptidoglycan synthesis 
inhibition by 7b-BF4. As expected, HADA incorporation was affected 
and eventually blocked in the presence of 7b-BF4 (Table 5). Compared 
to incorporation of 3H-labelled glucosamine followed by scintillation 
counting, the observation of HADA using fluorescence microscopy is 
simpler and faster. Therefore, we also analyzed several different con-
ditions, described in Table 5.
In a similar manner observed for glucosamine incorporation, we 
observed that the incorporation of HADA is visibly decreased when 
0.43 µg/mL (1 × MIC) of 7b-BF4 is applied to exponentially growing 
Figure 4: Effects of 7b-BF4 on the four major macromolecular synthesis pathways in 
comparison to negative controls (-) and antibiotics with specific activities targeting 
DNA, RNA, Protein, and peptidoglycan synthesis, Ciprofloxacin (Cip), Rifampicin (Rif), 
Tetracycline (Tet), and Vancomycin (Van) respectively. Each circle represents an experi-
mental replicate, bars indicate the median relative incorporation at each condition tested.
Table 5: Effect of 7b-BF4 in HADA incorporation.






Drug free 35 35 Yes
35 5 Yes
5 5 Yes
0.43 µg/mL 7b-BF4 35 35 Yes
5 5 Yes
35 5 No
1.72 µg/mL 7b-BF4 35 35 No
5 5 No
35 5 No
2.0 µg/mL Vancomycin 5 5 No
100 µg/mL Kanamicin 5 5 Yes
Figure 5: Overlays of phase contrast and HADA labelling (cyan) in the following condi-
tions: (A) 35 min. (B) 35 min with 0.43 µg/mL 7b-BF4. (C) 5 min with 1.72 µg/mL 7b-BF4. 






























































3.8. 7b-BF4 decreases intracellular ATP concentration
7b-BF4 contains lansoprazole as a ligand for its two gold atoms. Lan-
soprazole is used to treat peptic diseases due to its inhibitory effect on 
vacuolar H-ATPases (49). Lansoprazole does not affect bacterial F-Type 
ATPases. However, it is shown that in Mycobacterium tuberculosis lanso-
prazole is converted into lansoprazole sulfide inhibiting cytochrome 
bc1 and reducing intracellular ATP levels (17). The effect of 7b-BF4 and 
lansoprazole on the ATP concentration in B. subtilis cells was deter-
mined using a luminescence assay. After 30 minutes in the presence of 
3.6. 7b-BF4 does not disrupt the permeability of the 
membrane
Most antibiotics target either DNA, RNA, protein, or peptidoglycan syn-
thesis (44). However, some of them, such as polymixins, paenibacterin, 
and daptomycin target the cellular membrane, creating membrane 
pores (45–47). Pore formation affects all biosynthesis routes and thus 
could explain the effects detected in the incorporation assays. Pore 
formation can be detected with the bacterial viability kit Live/Dead 
 BacLight, which is based on the use of two fluorescent DNA stains, one 
of which, SYTO 9, is membrane permeable, and one of which, propid-
ium iodide, is membrane impermeable.
B. subtilis cells treated with 7b-BF4 for 15 min were primarily green, 
a sign of intact membranes as this means only SYTO 9 has been able 
to bind DNA (Table 6, A). A control experiment with the pore forming 
peptide nisin revealed orange cells, indicative of membrane damage 
which allowed propidium iodide to bind DNA and quench the SYTO 9 
signal (Table 6, B). Two concentrations of 7b-BF4 were tested and no 
membrane damage was observed compared to the control when over 
200 cells were analyzed, Table 5. Because the kit is meant to detect the 
viability of bacterial populations, one could think all green cells are 
viable. However, they can still maintain their membrane integrity for 
a short period of time while being metabolically inactive (48). This is 
likely to be the case in cells exposed to 7b-BF4 at 4 × MIC (1.72 µg/mL) 
for 15 min shown in Table 6. For this reason we conclude that 7b-BF4 
does not affect membrane permeability.
3.7. 7b-BF4 doesn’t disrupt membrane potential
Next to pore formation, the dissipation of the membrane potential 
would affect membrane bound processes in the cell. The possible effect 
of 7b-BF4 on the membrane potential was tested using the fluorescent 
dye DiSC3. This fluorophore inserts into polarized membranes upon 
which fluorescence is quenched. Loss of membrane potential results in 
the release of the dye from membranes and thus an increase in fluores-
cence (29). This rapid increase in fluorescence of DiSC3 was observed 
when B. subtilis cells were treated with nisin, whereas 7b-BF4 at various 
concentrations gave results similar to the control (Figure 6). Thus, we 
conclude that 7b-BF4 does not disrupt membrane potential.
Table 6: Membrane permeability of B. subtilis cells treated with 7b-BF4 and nisin. (A) 
cell treated with 7b-BF4 1.72 µg/mL (4 × MIC). (B) Cell treated with nisin. Scale bar 1 µm.
Condition Count Green Red/ 
Orange
Permeable
Control 240 228 12 5 %
Nisin 5 µg/mL 226 0 226 100 %
7b-BF4 0.43 µg/mL 257 248 9 3.5 %
7b-BF4 1.72 µg/mL 244 234 10 4.1 %











C 3  Nisin 32 x MIC
 4 x MIC
 1 x MIC
 Control
Figure 6: Fluorescence of DiSC3 after treatments with 1.5 µg/mL nisin or several con-







































































4 times MIC and a lower decrease for lower concentrations. However, 
the variation between replicates was higher thus the accuracy of the 
experiment was lower (results not shown).
3.9. Effect of 7b-BF4 in subcellular localization of MinD, 
DivIVA, and RpsB 
To further characterize the mode of action of 7b-BF4, we tried to observe 
GFP-tagged proteins that can serve as markers for the mode of action 
of antibiotics (30). For example, GFP-MinD can be used as an indicator 
of intact membrane potential — normally localized at cell poles, GFP- 
MinD loses this location when membrane potential is disrupted (35). 
In agreement with the result of the membrane potential assay above 
(Figure 6), GFP-MinD localization was not affected by 7b-BF4, whereas 
GFP-MinD localization was disrupted by nisin (Figure 8A).
We also observed that the localization of DivIVA is not disrupted even 
after 40 minutes in the presence of 1.72 µg/mL of 7b-BF4 (Figure 8B). 
This indicates that 7b-BF4 does not causes alterations in membrane cur-
vatures as DivIVA binds to negatively curved membranes (50). We also 
observed that DivIVA localization is very stable, it is clearly seen in cells 
after treatments of 40 minutes with 1.5 µg/mL of nisin or 1.72 µg/mL 
of 7b-BF4, that in those conditions are in their majority irreversibly 
inactivated.
7b-BF4 was able to block protein synthesis at 4 × MIC even more ef-
fectively than tetracycline at 10 × MIC (Figure 4). Therefore, we tested 
the localization of the ribosomal protein RpsB-GFP in the presence of 
either 7b-BF4 (4 × MIC) or tetracycline (10 × MIC). We observed that 
localization of RpsB-GFP is completely lost in the presence of 7b-BF4 
(Figure 8C). This result is similar to the observations of RpsB-GFP in 
cells treated with rifampicin (RNA synthesis inhibitor) by Hunt et al. 
(51), while the treatment of B. subtilis with protein synthesis inhibitors 
such as tetracycline causes the nucleoid to compact (51), thus affecting 
RpsB-GFP characteristic localization, away from the nucleoid Figure 8 C.
We could not draw conclusions from the localization pattern obtained 
from the other fluorescent protein fusions observed (YFP-FtsA, GFP-
FtsZ, RpoC-GFP, PolC-GFP, GFP-MreB; GFP-MreD, GFP-MreC, Spo0J-GFP, 
and Hbs-GFP). This was due to the fact that the localization pattern 
was not visibly different between untreated cells and cells treated with 
8.8 µg/mL of lansoprazole the cellular ATP levels are similar to those of 
untreated cells, whereas 7b-BF4 caused a sharp drop in ATP, similar to 
the positive control CCCP (Carbonyl cyanide m-chlorophenyl hydrazone) 
(Figure 7). The result with lansoprazole (HL2 in Table 3) is in accordance 
with it having no antimicrobial activity against B. subtilis (results not 
shown), Xac, E. coli, or L. lactis (Table 3). Therefore, the antimicrobial 
activity of 7b-BF4 is likely not to be caused by the lansoprazole scaffold 
but by the combination of the gold atoms and the triphenylphosphine 
moieties. The sharp decrease in ATP concentration caused by 7b-BF4 
is a possible explanation for the fact that all the four macromolecular 
synthesis routes tested were affected by 7b-BF4, because ATP is required 
for DNA, RNA, protein, and peptidoglycan synthesis.
We also determined cellular ATP concentrations after treatments of 
5 minutes. Here, the decrease in ATP concentration was dependent on 
the concentration of 7b-BF4, with a sharp decrease in cells treated with 
Figure 7: ATP concentration (relative light units) after 30 min treatments of B. subtilis 
cells with CCCP; Lansoprazole (LZ); or 7b-BF4 concentrations relative to the MIC con-
centration (0.5, 1, 2, or 4). 100 % was defined as the median luminescence of the control 
sample (without any compound added), each circle represents a replicate, bars indicate 
































































activity. 7b-BF4 killed the six Gram-positive bacteria tested, including 
multi drug resistant clinical isolates (MRSA and VRE). Further tests on 
B. subtilis revealed that 7b-BF4 does not target the cellular membrane 
nor disrupts membrane potential, but it affects DNA, RNA, protein, and 
peptidoglycan synthesis, and causes a sharp decrease in intracellular 
ATP concentration. Our results suggest that the mode of action of  7b-BF4 
is to disrupt ATP synthesis, which is necessary for macromolecular 
synthesis. 
The only antibiotic currently in use that targets ATP synthesis is 
bedaquiline that targets Mycobacterium tuberculosis (52). More recently, 
lansoprazole sulfate has also been reported to disrupt ATP production 
in M. tuberculosis (17). We tested the antimicrobial activity of 7b-BF4 on 
B. subtilis, which unlike M. tuberculosis is still able to undergo cell growth 
and division in the absence of an operon coding for ATP synthase us-
ing substrate level phosphorylation as a means of energy generation 
(53, 54). Substrate level phosphorylation is possible via glycolysis (53, 
55), and in our experiments, 7b-BF4 killed B. subtilis in medium con-
taining glucose (DMM) as effectively as medium without addition of 
glucose (LB). We also tested its activity against the anaerobic bacteria 
L. lactis in M17 medium, that contains glucose, and the MIC against 
this bacteria was in the same range as other Gram-positives tested. 
Therefore, we speculate that the decrease in ATP caused by 7b-BF4 is 
not (solely) from targeting F-type ATPases or other enzymes involved 
in ATP production via oxidative phosphorylation, like bedaquiline or 
lansoprazole sulfate. Additionally, drugs targeting ATPases bind at a 
specific region of the protein (56). This region is prone to changes 
via single-step mutation, which leads to resistance. Since we failed 
to obtain mutants resistant to 7b-BF4, it is likely that the compound 
has multiple targets. Another possibility is that developing resistance 
to 7b-BF4 requires the modification of multiple enzymes. This is the 
case with vancomycin, which targets D-Ala-D-Ala amino acids in na-
scent peptidoglycan, for example (57). Alternatively, it could also be a 
target that does not mutate easily due to the mode of action, such as 
in the case of linezolid that targets protein synthesis by blocking the 
initiation complex (58). The propensity for selection of resistance for 
linezolid is lower than protein synthesis inhibitors that act by blocking 
the elongation complex (58). 
other compounds used as controls (nisin, rifampicin, or CCCP) which 
made it impossible to validate the localization assay for these fusions. 
3.10. Probability of resistance is low
An assessment of the ability of an antimicrobial compound to select 
for resistant mutants is a crucial step in the development of an antibi-
otic (36). Additionally, we could get a hint about the mode of action of 
 7b-BF4 by characterizing resistant mutants. However, we were unable 
to generate mutants when seeding around 2 × 109 cells of B. subtilis cells 
in LB agar plates containing 21.5 µg/mL or 8.6 µg/mL of 7b-BF4. In total 
4 plates were made, and there were no colonies observed after 96 hours 
of incubation. Based on the number of cells tested, this result indicates 
that the chance of developing resistance through a single mutation 
event is lower than 10−8. Resistance mutation frequencies higher than 
10−6 could hamper the potential of 7b-BF4 as an antibiotic (36). 
4. Discussion
The rapid development of antibiotic resistance warrants the search 
and discovery of compounds which target different aspects of bacte-
rial growth and division (9). To this end, we screened 22 compounds 
for antimicrobial activity. Of these, 7b-BF4 presented the most potent 
Figure 8: Subcellular localization of GFP labelled proteins in B. subtilis strains. (A) TB35 
treated with 7b-BF4 or nisin for 5 minutes. (B) 1803 treated with 7b-BF4 or nisin for 



































































of toxicity could be helpful to understand the mode of action of this 
compound in bacteria, and eventually the compound could be modified 
to have lower toxicity and/or higher antimicrobial activity (67, 68). 
One example is linezolid, that was developed from more toxic and less 
effective oxazolidinones (69). 
In conclusion, we have shown that 7b-BF4 is a strong antimicrobial 
agent against Gram-positive bacteria. The mode of action of this com-
pound is still unknown, but it seems to be different from other known 
antibiotics and further tests are needed to characterize its mode of 
action.
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Xanthomonas citri subsp. citri (Xac) is a bacterial phytopathogen that 
can infect nearly all the commercially important plants of sweet orange 
and is a major threat to their industry (1). This organism causes citrus 
canker, and the most effective way to control the disease is to eradicate 
infected trees. However, the pathogen can infect the trees before being 
detected (2). Sprays of copper-containing bactericides in the field are 
another measure of control, which have resulted in resistant strains 
(3). In addition copper is stable and accumulates in the soil which has 
a negative impact on bacterial richness (4).
New antimicrobials are needed to tackle the problem of phytopatho-
gens infecting citrus plants. In this study, we focus on the antimicrobial 
activity of chalcones. Chalcones are plant derived compounds, which 
belong to the class of flavonoids, they are constituted by two aromatic 
rings linked by α,β-unsaturated ketone (enone bridge). There have 
been several studies reporting biological activities from the chalcones, 
including their potential use as antibiotics. Chalcones are secondary 
metabolites from plants. They are precursors of flavonoids and isofla-
vonoids that belong to the plant defense mechanisms, which prevent 
damage by microorganisms, insects and animals and counteract reac-
tive oxygen species preventing molecular damage (5). Chalcones have 
antioxidant, anti-inflammatory, antitumor, antimitotic, cytotoxic, and 
anti-infection activities, as reviewed in (6, 7). Due to their relatively low 
redox potential, they have a great probability of undergoing electron 
transfer reactions. 
Many chalcones have been studied for their antimicrobial activity (5, 
8). Licochalcone A, naturally produced by the roots of Glycyrrhiza inflata 
has activity against Bacillus subtilis and Staphylococcus aureus, and is able 
to prevent their growth at 3 μg/mL. However, this compound shows 
no activity against Gram-negative bacteria (9, 10). Licochalcone A was 
shown to inhibit oxidation of NADH and oxygen consumption in Micro-
coccus luteus (10) and induce membrane permeability in S. aureus (11). 
Despite being inactive against Gram-negative bacteria, Licochalcone A 
is able to inhibit NADH oxydases in membranes isolated from Escherich-
ia coli and Pseudomonas aeruginosa suggesting that the compound cannot 
penetrate the outer membrane (10). Accordingly, some chemically 
modified chalcones are effective against Gram-negative bacteria (5, 11) 
Abstract
Xanthomonas citri subsp. citri (Xac) is the causal agent of citrus canker, a 
severe disease that affects citrus crops, decreases fruit production and is 
a major threat to the orange industry. The most effective way to control 
the disease is to eradicate infected trees. New antimicrobials are need-
ed to combat citrus canker. To this end we explored the antimicrobial 
activity of chalcones. Chalcones are plant derived compounds, which 
belong to the class of flavonoids, which consist of two aromatic rings 
linked by an α,β-unsaturated ketone (enone bridge). In this chapter we 
present investigations on the mode of action of the methoxychalcone 
BC1 and the hydroxychalcone T9A against Xac and the model organism 
Bacillus subtilis. We have tested the minimum inhibitory activity (MIC) 
and, under the conditions tested, BC1 and T9A prevented growth of Xac 
and B. subtilis in concentrations varying from 20 µg/mL to 40 µg/mL. 
BC1 and T9A decreased incorporation of radiolabeled precursors of 
DNA, RNA, protein, and peptidoglycan in Xac and B. subtilis. The effect 
of the compounds on intracellular ATP concentration was small — in-
tracellular ATP was not decreased in B. subtilis and slightly decreased 
in Xac. Finally, the effect of chalcones on cell division was tested using 
GFP fusions to cell division proteins, they were not disrupted in Xac but 
we did observe a disruption in the localization of FtsZ-GFP in B. subtilis. 
However, a subsequent FtsZ GTPase activity assay did not support a 
direct action on FtsZ. The data produced in this work do not allow us 
to draw a conclusion about a specific mode of action of the compounds 
tested and further research is required to understand the mode of action 














































2.1. Minimal inhibitory concentration assays
The minimal inhibitory concentration (MIC) of compounds (Figure 1) 
was tested by broth microdilution. BC1 and T9A were tested against 
Xac and B. subtilis.
Exponentially growing bacteria were diluted to OD600 of 0.005 in 96 well 
plates containing two-fold serial dilutions of the compounds, in a final 
volume of 200 µL of growth medium. Davis Minimal Medium (DMM): 
casamino acids 2.0 g/L; K2HPO4 7.0 g/L; KH2PO4 3.0 g/L;  MgSO4·7(H2O) 
0.1 g/L; (NH4)2SO4 1.0 g/L; Na3C6H5O7·2(H2O) 0.5 g/L; glucose 7.0 g/L and 
tryptophan 10 mg/L; modified from (16, 17), was used for B. subtilis. Xam1 
medium: glycerol 2.46 g/L; MgSO4·7H2O 0.247 g/L; (NH4)2SO4 1.0 g/L; 
K2HPO4 10.5 g/L; KH2PO4 4.5 g/L;  Na3C6H5O7·2H2O 0.5 g/L; casamino 
acids 0.3 g/L; BSA 1 g/L; (pH 5.4 adjusted with HCl) was used for Xac. The 
MIC was defined as the lowest concentration of compound that prevented 
bacterial growth after incubating 24 hours at 30 °C (18).
2.2. Membrane permeability assay
Membrane permeability was tested using the commercial assay Live/
Dead BacLight bacterial viability kit (Thermo-Scientific). An overnight 
culture of B. subtilis grown in LB, or Xac grown in NYGB (Chapter 2), 
at 29 °C, was diluted to 106 cells per mL. B. subtilis cells were incubated 
including Mycobacterium tuberculosis (12). The anti-tubercular activity 
is associated with inhibition of the protein tyrosine phosphatase B (12). 
Phloretin, a chalcone present in apple and kumquat, is effective only 
against Gram-positive bacteria (13). This compound inhibits acetate 
dehydrogenase, isocitrate dehydrogenase, and catalase from S. aureus 
(13). DNA gyrase was reported to be a target for synthetic chalcones 
active against both Gram-positive and Gram-negative bacteria (14).
In a recent study our collaborators identified and synthesized chal-
cones substituted by hydroxyl groups (hydroxychalcones) and tested 
their antibacterial activity against S. aureus and Pseudomonas aeruginosa 
(Ayusso et al., in preparation). The most active compound against S. au-
reus, T9A (Figure 1, hydroxychalcone 5, Table 1), inhibited growth of 
both bacteria albeit with a 16 fold higher minimal inhibitory concentra-
tion (MIC) for the Gram-negative bacteria. As the minimal bactericidal 
concentration (MBC) for this compound could not be determined, it 
appears that T9A stops growth but does not kill the bacterial cells. BC1, 
a methoxychalcone, was synthesized by our collaborators inspired 
by a simplified curcumin compound with antibacterial activity (15) 
(Figure 1). As BC1 and T9A both display antimicrobial activity against 
Xac (see below), we decided to further characterize their mode of ac-
tion. Here, we tested the influence of T9A and BC1 on macromolecular 
synthesis (DNA, RNA, protein, and peptidoglycan), ATP concentration, 









Figure 1: Structures of the compounds used in this study.
Table 1: Structures and minimum inhibitory concentration of hydroxychalcones synthe-
sized and tested by (Ayusso et al., in preparation). MIC50 is the concentration necessary 
to cause 50 % decrease in resazurin reduction by S. aureus (Sa) or P. aeruginosa (Pa) cells 
after 24 hours in the presence of the compound, values displayed are in µg/mL.
Compound MIC50 Sa MIC50 Pa R R’
3 12.5 50.0 3’-hydroxyphenyl phenyl
4 50.0 100 4’-hydroxyphenyl phenyl
5 (T9A) 6.2 100 phenyl 2-hydroxyphenyl
6 25.0 50.0 phenyl 3-hydroxyphenyl
vancomycin 2.0 - - -



































































For every precursor tested, at least 8 technical replicates were taken, 
from 4 biological replicates. During incubation, aliquots were taken 
and precipitated with ice-cold 12 % trichloroacetic acid for 35 min and 
then filtered through nitrocellulose membranes (pore size 0.45 μm). The 
filters were washed with ice cold 12 % trichloroacetic acid, transferred to 
2 mL scintillation fluid Ultima Gold MV (PerkinElmer), and measured in 
a Tri-Carb 2000CA liquid scintillation analyzer (Packard Instruments).
2.4. Resazurin assay
The Resazurin assay (REMA) was performed in order to evaluate the 
impact of the compounds on the respiratory activity after a short pe-
riod of time. Cells of B. subtilis or Xac were incubated in contact with 
resazurin in the same medium used for MIC evaluations (DMM and 
Xam1 respectively) in 96-well plates. The compound BC1 was used at a 
final concentration of 40 µg/mL for B. subtilis and 30 µg/mL for Xac; T9A 
was used at 40 µg/mL for B. subtilis and 20 µg/mL for Xac. Rifampicin 
0.625 µg/mL, ciprofloxacin 0.625 μg/mL, tetracycline 10 μg/mL, and 
vancomycin 1.0 μg/mL were used as controls for B. subtilis and rifam-
picin 0.625 µg/mL, ciprofloxacin 10.0 μg/mL, tetracycline 10 μg/mL, 
and penicillin G 800 μg/mL were used as controls for Xac, along with 
samples without added compound. Resazurin was added to a final con-
centration of 0.1 mg/mL. Fluorescence (excitation 530 nm, emission 
560 nm, bandwidth 9 nm) was recorded every 20 min up to 120 min in 
a BioTek Synergy Mx 96-well plate reader. 
2.5. Intracellular ATP concentration assay
ATP levels were measured in B. subtilis and Xac using the BacTiter-Glo™ 
Microbial Cell Viability Assay (Promega). CCCP (Carbonyl cyanide 
m-chlorophenyl hydrazine, 40 µg/mL) was used as a positive control 
for ATP depletion in Xac, and 7b-BF4 (Chapter 2) was used as control 
for ATP depletion in B. subtilis (1.72 µg/mL). The cells were incubated 
in a 96 well plate (30 °C, 1000 rpm), 30 min for B. subtilis (in DMM) and 
80 min for Xac (in Xam1) after which 100 µL of cell culture was added 
to 100 µL of BacTiter-Glo™ Reagent for 5 minutes in a white 96 well 
plate (26 °C, 1000 rpm). Luminescence was measured in a Tecan Infinite 
F200 Pro luminometer. The amount of light emitted is a measure for 
the intracellular ATP concentration.
in the presence of BC1 (50 µg/mL), T9A (40 µg/mL), DMSO (1 %) as a 
negative control, and nisin (5.0 μg/mL) as a positive control; Xac cells 
were incubated in the presence of BC1 (90 µg/mL), T9A (50 µg/mL), 
DMSO (1 %) as a negative control, and 20 min at 60 °C as a positive 
control; for 15 min and 30 min at 23 °C. Propidium iodide (5.0 mM) and 
SYTO 9 (835 µM) were added to each test. After incubation, cells were 
mounted on agarose pads for microscopy analysis and the green and 
red fluorescence were imaged using an Olympus BX61 microscope with 
an OrcaFlash-2.8 camera using DAPI/FITC and Texas Red fluorescence 
filter cubes. Propidium iodide (shown in Texas Red fluorescence filter) 
is membrane impermeable and thus only stains cells with disrupted 
membrane, whereas SYTO 9 (shown in DAPI/FITC fluorescence filter) 
is membrane permeable and stain all the cells. The Olympus cellSens 
platform was used for image analysis.
2.3. Macromolecular synthesis
Four macromolecular synthesis pathways were evaluated by moni-
toring the incorporation of radioactively labelled precursors. [53H]
uridine, [methyl3H]thymidine, L[3,4,53H(N)]leucine and D[63H(N)]
glucosamine hydrochloride (all at 0.5 µCi/mL) were used to respectively 
monitor RNA, DNA, protein and peptidoglycan synthesis. During this 
experiment B. subtilis cells were grown to early exponential phase in 
DMM and Xac cells were grown to early exponential phase in Xam1. 
1 mM of non-labelled precursor was used for RNA and peptidoglycan 
and 10 µM was used for DNA and protein. For DNA incorporation, B. sub-
tilis cells were grown in LB medium instead of DMM.
Cells were incubated in the presence of labelled precursors for up to 
80 minutes with shaking at 30 °C. B. subtilis was tested in the presence 
of 40 µg/mL of BC1 or T9A, without compound (negative control), or 
with an antibiotic known to inhibit the synthesis pathway tested as a 
positive control (RNA: rifampicin 0.625 µg/mL, DNA: ciprofloxacin 
0.625 μg/mL, protein: tetracycline 10 μg/mL, peptidoglycan: vanco-
mycin 1.0 μg/mL). Xac was tested in the presence of 30 µg/mL of BC1, 
20 µg/mL of T9A, without compound (negative control), or with an 
antibiotic supposed to inhibit the synthesis pathway tested as positive 
control (RNA: rifampicin 0.625 µg/mL, DNA: ciprofloxacin 10.0 μg/mL, 














































Król et al. (21), with a few modifications. Stocks of BC1 (50 µg/mL), T9A 
(40 µg/mL), and DMSO (1 %) as a negative control, with FtsZ (24 µM), 
MgCl2 (20 mM) and Triton X-100 (0.02 %) prepared in polymerization 
buffer (Hepes 50 mM, KCl 300 mM, pH 7.5) were stabilized at 30 °C 
for 5 min. Then, GTP dissolved in the same buffer was added (1 mM 
final concentration) at different time points (0, 2.5, 5, 10, 15, 20, and 
30 min). The reactions were kept at 30 °C and developed in accordance 
with Malachite Green Phosphate Assay Kit (MAK307, SigmaAldrich).
2.8. Stimulation of resistance
For resistance development by sequential passaging, 2 parallel popu-
lations of Xac were diluted in NYGB medium containing 2 fold serial 
dilutions of BC1 or T9A (starting with 10–160 µg/mL), during the expo-
nential phase, similar to the method described by Oz et al. (22). Each day, 
those cells that grew at the highest concentration of drugs were diluted 
to fresh medium containing serial dilutions of antimicrobial. Dilutions 
were done after about 24 h of growth at 29 °C over a period of 23 days.
3. Results
3.1. Minimal inhibitory concentration
First, we needed to decide the minimum inhibitory concentration of BC1 
and T9A for our chosen model organisms, Xac and B. subtilis, which was 
done by a standard broth microdilution assay (Table 2). Xac is slightly 
more sensitive to the compounds when compared to B. subtilis. Com-
pared to the earlier results from our collaborators, we note that B. subtilis 
is less sensitive to BC1 as the Gram-positive model S. aureus, whereas 
Xac is more sensitive compared to the Gram-negative P. aeruginosa. 
However, as our collaborators assayed MIC by determining metabolic 
2.6. FT‐IR spectrophotometry
Fourier-transform infrared (FT-IR) spectrophotometry was done on 
B. subtilis cells in a FT‐IR spectrophotometer (Shimadzu, model 8300), 
as described by Morão et al. (15). Cells were cultivated in LB medium 
(29 °C) up to the concentration of 105 cells/mL, then treated with BC1 
(50 µg/mL), T9A (40 µg/mL), nisin (5 µg/mL), or a negative control 
without addition of extra compounds for 30 min. Aliquots of 1.5 mL of 
cells were then centrifuged at 10 000 g for 2 min, washed with water 
and centrifuged two more times to remove traces of medium. After 
that, the samples were mixed with 150 mg of KBr, dried at 50 °C for 
24 h, homogenized and compressed at 40 kN for 5 min. Absorbance was 
measured from 400 cm−1 to 4000 cm−1, with 32 scans at a resolution of 
4 cm−1. Data treatment and analyses were performed using the software 
Origin 8.00.
2.7. Cell division investigations 
The effect of chalcones on cell division was investigated using GFP 
fusions to cell division proteins, and by evaluating the GTPase activity 
of FtsZ from B. subtilis.
Xac labeled with GFP-ZapA (Xac amy::gfp-zapA, Chapter 4, Table 1) 
was grown in NYGB and induced with Xylose (0.5 %) for 90 min. Cells 
were treated with BC1 (90 µg/mL), T9A (50 µg/mL), DMSO (1 %, as a 
negative control) or hexyl gallate (60 µg/mL, as a positive control) for 
30 min and samples were prepared and visualized in the microscope 
as described in section 2.2. GFP fluorescence was visualized in GFP 
filter cubes. 
B. subtilis labeled with FtsZ-GFP (15) was cultivated in presence of 
0.02 mM IPTG (isopropyl-β-D-1-thiogalactopyranoside) to induce the 
expression of the protein fusion from pspac promoter. Cells were treated 
with BC1 (50 µg/mL), T9A (40 µg/mL), DMSO (1 %) as a negative control, 
and hexyl gallate (60 µg/mL) as a negative control for 15 and 30 minutes. 
Samples were prepared and visualized in the microscope as described 
in section 2.2. GFP fluorescence was visualized in GFP filter cubes. 
FtsZ from B. subtilis was expressed and purified using the ammonium 
sulfate precipitation method as described by Mukherjee & Lutkenhaus 
(19) and Król & Scheffers (20). The FtsZ GTP hydrolysis rate was de-
termined using the malachite green phosphate assay as described by 



























































grows slower than organisms such as B. subtilis and E. coli, which are 
routinely used for these assays. It turned out that a period of 80 min 
was sufficient to measure label incorporation, and that incorporation 
over this time period was linear (Figure 2) indicating that the bacteria 
continued growing under the experimental conditions used. As control 
for each macromolecular synthesis pathway, an antibiotic was included 
that targets the specific pathway. Because BC1 and T9A were tested 
at MIC, the MICs for the control antibiotics were determined — and 
penicillin instead of vancomycin was used to inhibit peptidoglycan 
synthesis in Xac.
Results of each of the macromolecular synthesis pathways tested can 
be seen in Figure 3. As is evident, both compounds inhibit all pathways 
to some extent in both Xac and B. subtilis, with the sole exception of 
T9A that does not affect DNA synthesis in B. subtilis. Also, in all cases 
BC1 is more effective at blocking macromolecular synthesis than T9A. 
Finally, whereas all control antibiotics are very effective in blocking 
their respective pathways in B. subtilis, the block is not so strong in 
activity after incubation for 24 h with the drug using resazurin, the 
results cannot be directly compared (short incubations already strongly 
affect the metabolic activity of the cells, see below). We used the MIC 
values to guide our assays to determine the drugs’ mode of action.
3.2. Membrane permeability
Then, we tested whether these compounds are capable of disrupting 
the membrane, which is a mode of killing that we observed earlier with 
gallic acid derivatives, compounds with aromatic rings (23, 24). T9A 
had no effect on the membrane of both B. subtilis and Xac, whereas BC1 
did not affect Xac but did affect B. subtilis membranes (Table 3). The last 
observation in combination with the fact that BC1 has a slightly lower 
MIC for Xac than for B. subtilis, suggests that its mode of action may be 
different between the two organisms.
Images of Xac and B. subtilis cells stained with propidium iodide and 
SYTO 9 can be seen in Figure S1.
3.3. Macromolecular synthesis
Subsequently, we tested whether BC1 or T9A inhibit the synthesis of 
the macromolecules DNA, RNA, proteins and peptidoglycan using ra-
diolabeled precursors of each macromolecule and following their in-
corporation. Although these assays are common practice in antibiotics 
research we needed to establish conditions for Xac as this bacterium 
Table 3: Permeabilization of Xac and B. subtilis cells by chalcones and controls.
Condition Xac cells (mean ± SD) B. subtilis cells (mean ± SD)
Negative control 2.38 ± 0.08 % 2.86 ± 1.78 %
DMSO 1 % 2.95 ± 0.53 % 4.02 ± 3.16 %
BC1 (90/50 µg/mL; 15 min) 2.22 ± 1.34 % 66.23 ± 0.62 %
BC1 (90/50 µg/mL; 30 min) 6.98 ± 1.67 % 75.32 ± 0.28 %
T9A (50/40 µg/mL; 15 min) 2.91 ± 0.89 % 3.67 ± 0.63 %
T9A (50/40 µg/mL; 30 min) 3.86 ± 0.22 % 4.81 ± 3.29 %
Heat shock (60 °C; 20 min) 97.16 ± 0.76 % not done
Nisin (5.0 g/mL; 15 min) not done 97.22 ± 2.72 %

















































Time (min) Time (min)
Time (min)
[5‑3H]uridine (RNA)
[methyl‑3H]thymidine (DNA) L‑[3,4,5‑3H(N)]leucine (protein)
Figure 2: Incorporation of radiolabels in Xac over time. Cells were grown in Xam1 at 























































Xac with only tetracyclin blocking protein synthesis almost completely 
(see discussion).
3.4. Resazurin assay
To determine whether the inhibition of macromolecular synthesis 
was specific or caused by cells dying, the metabolic activity of the 







































- BC1 T9A   Cip  - BC1 T9A   Rif   - BC1 T9A   Tet      - BC1   T9A   Van   
A
DNA            RNA                  Protein              Cell WallB
Figure 3: Effects of BC1 and T9A on the four major macromolecular synthesis pathways 
of: A Xac, B B. subtilis, in comparison to negative controls (-) and antibiotics with specific 
activities targeting DNA, RNA, Protein, and Peptidoglycan synthesis, Ciprofloxacin (Cip), 
Rifampicin (Rif), Tetracycline (Tet), and: A Benzyl penicillin (PenG), B Vancomycin (Van), 
respectively. Each circle represents an experimental replicate; bars indicate the median 
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1231 cm−1 are due to PO2− asymmetric stretching, mainly from nu-
cleic acids with little contribution from phospholipids. The peaks at 
1404 cm-1corresponds to COO− symmetric stretching from aminoacid 
side chains and fatty acids. The peaks at 1450 cm−1 are due to CH2 bend-
ing from lipids. The peaks at 1540 cm−1 are from N-H bending and C-N 
cells in the presence of BC1, T9A and pathway specific antibiotics was 
measured using the REMA assay. This assay is based on the reduction 
of resazurin to resorufin as a result of bacterial respiration (25). Cells 
(Xac or B. subtilis) were mixed with the compounds/antibiotics and 
their metabolic activity was measured in 20 minutes intervals for up 
to 120 minutes (Figure 4). For Xac, this showed that even though there 
was some inhibition of metabolic activity, this did not go below 75 % 
of uninhibited activity, nor displayed a large decline over the 2 h that 
activity was followed. Thus, inhibition of synthesis pathways to levels 
below 70 % in Figure 3 is not caused by overall cell death. For B. subtilis 
the results were different, and rather puzzling. T9A almost completely 
blocked metabolic activity, similar to control compound 7b-BF4, which 
is striking as the effect of T9A on macromolecular synthesis in B. subtilis 
was not very pronounced. BC1 reduced the respiration to about 60 %.
3.5. Intracellular ATP concentration
The relative intracellular ATP levels were determined in Xac and B. sub-
tilis after 80 or 30 min of compound treatments, respectively (Shown 
in Figure 5). At 1 × MIC, T9A and BC1 cause a decrease in Xac ATP 
levels compared to control to a similar extent as their effect on overall 
respiratory activity. BC1, at two times MIC led to a complete loss of 
ATP, when compared to the control CCCP (Figure 5A). Strikingly, in 
B. subtilis the ATP levels increased, which is especially surprising given 
the loss of metabolic activity caused by T9A (Figure 5B). This suggests 
that in the presence of these compounds cells may switch to anaerobic 
metabolism, together with an inhibition of ATP-consuming pathways. 
3.6. FT‐IR spectrophotometry
FT-IR of B. subtilis cells treated with BC1 and T9A was measured, to-
gether with a negative control and a positive control with nisin (shown 
in Figure 6). FT-IR is a technique that can provide a ‘fingerprint’ of 
different components of the bacterial cell, and thus can also report 
on the disruption of cellular structures (15). The peaks shown in the 
spectrum represent perturbations of diverse chemical structures from 
compounds present in B. subtilis (26). The peaks at 1083 cm−1 are due 
to stretching of C-O bonds present in glycogen and PO2− symmetric 










































Control   BC1x1   BC1x2   T9Ax1   T9Ax2    CCCP
A
Control   BC1x1   BC1x2    T9Ax1   T9Ax2    7b-BF4
Figure 5: ATP concentration (relative light units): A (after 80 minutes treatments of Xac 
cells), B (after 30 min treatments of B. subtilis cells), with 1x and 2x the MIC of BC1 or 
T9A or 40 µg/mL of CCCP. 100 % was defined as the median luminescence of the control 
sample (without any compound added), each circle represents a replicate, bars indicate 
































































We attempted to FT-IR on Xac cells as well. However, Xac produces 
xanthan gum and biofilms (27) generating noise on the spectra, thus 
preventing other compounds to be detected.
3.7. Cell division investigations 
Our last attempt to find a specific cellular process targeted by the chal-
cones was focused on cell division. Figure 7B-C shows that the localiza-
tion of GFP-ZapA, our marker for cell division, in Xac was not affected 
by BC1 or T9A. 
Figure 7F-G shows that the localization of FtsZ-GFP, our marker 
for cell division, in B. subtilis was affected by both BC1 and T9A. Since 
BC1 is able to disrupt membrane permeability in B. subtilis (disrupting 
membrane potential as well), it is possible that FtsZ-GFP localization 
is disrupted due to membrane potential disruption (28). However, T9A 
stretching from amide II present in α helixes of proteins. Finally, the 
peaks at 1646 cm−1 are from C=O stretching from amide I α helixes (26). 
The intensity of the spectrum of the negative control (Figure 6A) was 
similar to the spectrum of the cells treated with T9A (Figure 6D), and 
the intensity of the spectrum of cells treated with nisin (Figure 6B) 
was similar to the spectrum of the cells treated with BC1 (Figure 6D). 
We could not identify any obvious differences between the spectra 
regarding a particular peak. However, the similar intensities between 
the spectrum of the negative control and T9A and between BC1 and 
nisin, corroborates with the results of our membrane permeability 
assay (Table 3). In there we can see that T9A does not cause membrane 
disruption in B. subtilis whereas BC1 is able to disrupt the cellular mem-
brane similar to nisin.
Figure 6: FT-IR spectra of B. subtilis cells after 30 minutes treatments with (A) no com-
pounds added; (B) nisin (5 µg/mL); (C) BC1 (50 µg/mL); and (D) T9A (40 µg/mL).
Figure 7: Phase contrast (left) and GFP (right) images of: Xac labeled with GFP-ZapA treat-
ed for 30 min with (A) 1 % DMSO, (B) BC1 (90 µg/mL), (C) T9A (50 µg/mL), (D) hexyl gallate 
(60 µg/mL), and B. subtilis labeled with FtsZ-GFP treated for 30 min with (E) 1 % DMSO, 

























































We also tested the mode of action of these compounds in B. subtilis due 
to the ease of working and our experience with this organism in the lab.
Vancomycin does not affect Gram-negative bacteria (33), and Xac is 
resistant to ampicillin (34). Therefore we decided to use benzyl peni-
cillin as a control for cell wall incorporation, since this antibiotic was 
previously reported to be effective against Xac (35). We tested the 
minimum inhibitory concentration of benzyl penicillin in our lab and 
200 µg/mL was able to prevent Xac growth for 24 hours. Therefore, we 
used 4 times this concentration as a control for glucosamine incorpo-
ration (800 µg/mL). However, to our surprise Xac cells exposed to pen-
icillin were able to incorporate 92 % of glucosamine when compared to 
the control. This could possibly be due to benzyl penicillin having more 
affinity for penicillin binding proteins (PBPs) responsible for hydrolysis 
and less affinity for PBPs responsible for synthesis of peptidoglycan, 
thus cells could still build peptidoglycan and elongate without being 
able to undergo cell division, ultimately leading to cell death (36). 
The DNA synthesis inhibitor ciprofloxacin caused only 22 % reduction 
in thymidine incorporation when compared to the control. Incorpo-
ration of radiolabels in Xac might be less affected by known specific 
does not disrupt membrane permeability in B. subtilis, suggesting that 
the mode of action of T9A is linked to cell division. To investigate this 
in more detail we tested the effect of BC1 and T9A on the GTPase ac-
tivity of FtsZ.
Figure 8 shows that the GTPase activity of FtsZ was not affected by 
BC1 or T9A, indicating that FtsZ is not a direct target of the chalcones 
tested.
3.8. Resistance studies
Xac grown in sublethal concentrations of BC1 or T9A was able to devel-
op resistance and grow in higher concentrations of compound Figure 8. 
Resistance increased 2 fold every 3 days reaching a maximum of 4 fold 
(360 µg/mL) for BC1 and 8 fold (400 µg/mL) for T9A.
4. Discussion
Xac causes citrus canker leading to an economic impact on citriculture 
(1). In this chapter we investigated the antibacterial mode of action of 
the methoxychalcone BC1 and the hydroxychalcone T9A on Xac using 
techniques previously used to investigate the mode of action of drugs 
in B. subtilis and other organisms such as E. coli and S. aureus (29–32). 
Figure 8: GTPase activity of FtsZ in the presence of DMSO, BC1, or T9A. Figure 9: minimum inhibitory concentration of BC1 and T9A against an exposed popu-





























































a small decrease was observed (Figure 5A), which is an indication of 
indirect effect, but not as conclusive as in B. subtilis. 
Cell division process was investigated by observing the localization 
of GFP fusions with cell division proteins. In Xac neither BC1 or T9A 
caused delocalization of our cell division marker (GFP-ZapA) which 
rules out the possibility of those compounds to cause a direct effect in 
Xac cell division.
In B. subtilis both compounds caused delocalization of our cell divi-
sion marker (FtsZ-GFP). BC1 is able to permeabilize B. subtilis mem-
branes, therefore this result could be due to membrane potential dis-
ruption, similar to what was observed by Strahl, et al. (28). However, 
T9A is not able to permeabilize B. subtilis membranes. Therefore, we 
tested GTPase activity and since neither chalcone caused an effect in 
GTPase activity we rule out the possibility of cell division being directly 
affected by T9A or BC1.
The data produced in this work do not allow us to draw a conclusion 
about a specific mode of action of the compounds tested. However, we 
were able to generate Xac strains with resistance to T9A and BC1, which 
opens the possibility to sequence and carry out genomic analyses to 
understand the mode of action of this compounds.
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controls in 80 minutes due to possible delays in the compounds to pen-
etrate the outer membrane. Xac divides once every 5.1 hours in Xam1 
medium at 30 °C, therefore the time used for incorporation corresponds 
to only 26 % of a doubling time. Probably the metabolic processes in 
Xac are slower than in B. subtilis and the antibiotics take a longer time 
to kick-in. The concentration of ciprofloxacin used in this experiment 
was 10.0 μg/mL, which is 4 times the concentration necessary to inhibit 
Xac growth for 24 hours. 
There is also very limited published data to compare our controls 
with. Most publications about incorporation of radiolabeled precur-
sors do not report the use of antibiotics as positive controls (10, 30, 31, 
37–40). Three studies described macromolecular synthesis assay with 
antibiotics as a positive controls, but they were on the Gram-positive 
bacteria B. subtilis (29), S. aureus (41), and Staphylococcus simulans (32), 
and all of them used vancomycin as a control for blocking peptidoglycan 
incorporation. To our knowledge this is the first report on the incorpo-
ration of macromolecular precursors in Xac.
Despite not being able to detect a block of all the pathways with 
positive controls, our experiment showed that all the metabolic path-
ways are affected by the compounds within the 80 minutes monitored 
which is a strong indication of an aspecific mechanism. Similarly, for 
B. subtilis all the metabolic pathways are affected within the 60 minutes 
tested. This result is similar to what was obtained by Haraguchi et al. 
(10) when testing the mode of action of licochalcone A. This chalcone 
inhibited incorporation of DNA, RNA, and protein (peptidoglycan was 
not  tested) in Micrococcus luteus (10). In this case it is because lico-
chalcone A inhibits oxygen consumption and interferes with energy 
metabolism (10). Intriguingly, in our experiments we showed that both 
compounds (BC1 and T9A) caused an increase in ATP concentration 
in B. subtilis (Figure 5B). It could be that these compounds cause a 
switch of B. subtilis to anaerobic growth which causes ATP levels to be 
maintained (42), but the increase in ATP could also be due to processes 
such as cell wall and RNA synthesis being inhibited or blocked, causing 
a difference between ATP production and consumption. The latter effect 
was previously observed for the protein inhibitors chloramphenicol 
and streptomycin (43). From these results we can conclude that those 
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8. Supporting information
Figure S1: Xac and B. subtilis cells, phase contrast (left) and overlay of Texas Red and 















Due to the negative impact caused by Xac described in the previous 
chapters, we investigated the potential of alkyl gallates as an alternative 
to combat or prevent citrus canker. Alkyl gallates have been used as 
food additives (1), but also showed antimicrobial activity with potential 
inhibitory effect on cell division (2). Silva et al. (2) showed that pentyl, 
hexyl, heptyl, and octyl gallates disrupt the septum of Xac, raising the 
hypothesis that those compounds target cell division process. At the 
time, purification or characterization of Xac cell division proteins had 
not been established. Therefore, Król et al. (3) tested those alkyl gallates 
in vitro using Bacillus subtilis FtsZ. They tested GTPase and sedimenta-
tion activity of FtsZ in the presence of gallates, and binding of alkyl 
gallates to FtsZ, showing that FtsZ is a direct target for alkyl gallates 
in B. subtilis (3). In this short report we will discuss additional tests to 
further characterize the activity of alkyl gallates against Xac.
2. Methods
2.1. Minimal inhibitory concentration assays
The minimum inhibitory concentration (MIC) of pentyl, hexyl, heptyl, 
and octyl gallates was tested by broth microdilution. Exponentially 
growing Xac cells were diluted to OD600 of 0.005 in 96 well plates con-
taining two-fold serial dilutions of the compounds, in a final volume 
of 200 µL of NYGB medium (glycerol 20 g/L, peptone 5.0 g/L, and yeast 
extract 3.0 g/L). The MIC was defined as the lowest concentration of 
compound that prevented bacterial growth after incubating 24 hours 
at the indicated growth temperature (4).
2.2. Resistance development assay
For resistance development by sequential passaging, 2 parallel popu-
lations of Xac were diluted in NYGB medium containing 2 fold serial 
dilutions of heptyl gallate (starting with 5–80 µg/mL) or kanamycin 
(starting with 0.78–25 µg/mL), during the exponential phase, similar 
to the method described by Oz et al. (5). Each day, those cells that grew 
at the highest concentration of drugs were diluted to fresh medium 
containing serial dilutions of antimicrobial. Dilutions were done after 























































one population that grew at 25.0 µg/mL of kanamycin. The evolution 
of each population can be seen in Figure 1. The populations exposed 
to kanamycin had increased resistance and grew at a kanamycin con-
centration that was 8 times the initial MIC. However, the populations 
exposed to heptyl gallate remained as sensitive as wild type strains even 
after 23 days of growth in the presence of the compound.
In B. subtilis, the antibacterial activity of alkyl gallates is a combi-
nation of direct targeting of FtsZ and permeabilization of bacterial 
membranes (3). In our lab, we recently managed to purify Xac FtsZ 
and showed that the effects of alkyl gallates on Xac FtsZ are only mild 
[MBO3–2018–03–0093.R3]. Thus, it was necessary to test the effect 
of alkyl gallates on Xac membranes, especially since acetylated alkyl 
gallates were recently shown to permeabilize Xac membranes (6). We 
 tested membrane permeability by incubating cells with alkyl gallates 
and followed by fluorescent labelling with two DNA dyes, one mem-
brane permeable, the other membrane impermeable. This assay showed 
that at MIC (32 µg/mL), pentyl gallate permeabilized 42 % of Xac cells, 
and the other alkyl gallates permeabilized 94 % or more Xac cells (Ta-
ble 1), which is more than our positive control with nisin in combina-
tion with EDTA. Thus the alkyl gallates permeabilize Xac membranes.
2.3. Membrane permeability assay
Membrane integrity was assessed using the commercial Live/Dead 
 BacLight bacterial viability kit (Invitrogen) for microscopy, as previ-
ously tested in our lab by Król et al. (3), with some modifications for 
Xac. 100 μL aliquots of exponentially growing cells (OD600 ≈ 0.5, 30 °C, 
NYGB) were incubated for 45 min with either alkyl gallates at 32 μg/mL 
or Nisin (10 μg/ml) and EDTA (30 mM) as a control for permeabilization, 
or without treatment as a negative control. After 45 min, 0.3 µL of dye 
mixture (propidium iodide (5.0 mM) and SYTO 9 (835 µM), used as 
described by manufacturer) was added to the cells to stain the DNA — 
incubation was continued for 15 min and the cells were immediately 
imaged on agarose pads using bright-field, FITC (50 ms exposure), and 
TRITC (100 ms exposure) fluorescence filter cubes. Images were ana-
lyzed using the Fiji (https://fiji.sc/) software package, the function “Find 
Maxima” was used to automatically detect green and red fluorescent 
cells with thresholds of 11000 and 3000 respectively.
3. Results
The minimum inhibitory concentration measured in our lab was 32 µg/
mL for each of the alkyl gallates tested, which is identical to what was 
found by Silva et al. (2) (31.2 µg/mL), despite the differences in the way 
of measuring. Silva et al. (2) used LB medium and measured growth 
inhibition using a REMA assay, which measures the reductive capability 
of cells as a measure for cell viability, whereas we used NYGB medium 
and measured growth inhibition after 24 h in liquid. Since the minimum 
inhibitory concentration is measured by 2 fold dilutions (e.g. 16, 32, and 
64) the values of 32 µg/mL and 31.2 µg/mL can be considered identical. 
The minimum inhibitory concentration we measured for kanamycin 
for wild type Xac was 6.25 µg/mL.
For resistance development two populations of Xac cells were grown 
in duplicate in different concentrations of antimicrobials and each day 
the culture growing at the highest concentration was diluted to fresh 
medium with different concentrations of antimicrobial, allowing the 
gradual development of increased resistance. We chose heptyl gallate 
for this experiment as it was the most active inhibitor of B. subtilis 
FtsZ (3), and kanamycin as a control. After 23 days this resulted in one 
population that was able to grow in 20 µg/mL of heptyl gallate, and 
Figure 1: minimum inhibitory concentration of heptyl gallates and kanamycin for ex-




























































In this report we tried to develop resistant strains of Xac that are re-
sistant to heptyl gallate. This experiment provide initial information 
about the possibility of resistance development when alkyl gallates 
would be used in agriculture. Also, if we had found a resistant strain it 
could be helpful to characterize the mode of action of the compound 
as sequencing the strain would give indications about possible targets 
of the alkyl gallates. Alkyl gallates are FtsZ inhibitors in B. subtilis (3) 
and caused septum mislocalization in Xac (2) suggesting that FtsZ is 
also a target in this bacteria. In case of a single target the probability of 
resistance occurring would be from 106 to 109, which would be possible 
to generate in the lab, and the mutations would be probably related to 
the target (7). However, Xac could not develop resistance against heptyl 
gallate. This is an indication that the compound could have multiple 
targets, or a target that is not a protein. This fits our observation that the 
antibacterial activity of alkyl gallates against Xac is primarily caused 
by its effect on the membranes.
Table 1: Permeabilization of Xac cells by alkyl gallates.
Condition (n/n) Permeabilized cells (mean ± SD)
Control (10536/10010) 0.8 ± 0.2 %
pentyl gallate (308/268) 42.2 ± 0.3 %
hexyl gallate (457/858) 94.5 ± 4.2 %
heptyl gallate (1931/5701) 99.9 ± 0.1 %
octyl gallate (1523/3508) 99.8 ± 0.1 %
Nisin EDTA (452/5437) 94.0 ± 5.9 %
Results from two independent replicates, n represents the number of cells counted in each 
experiment.
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Xanthomonas citri subsp. citri (Xac) is the causal agent of citrus canker: a 
disease that affects citrus crops, decreases fruit production and causes 
economic losses (1). This disease is currently present in South and North 
America, Asia, Africa, and Oceania (2–5). The current strategy to com-
bat citrus canker in the state of São Paulo, Brazil, the largest producer 
of concentrate orange juice in the world, comprises the eradication of 
symptomatic trees along with spraying copper-containing bactericides 
in a radius of 30 m having the symptomatic tree as the center point (1, 
6). However, this strategy is costly and has limited effectiveness (3, 7). 
The genome of Xac was fully sequenced 14 years ago, opening up 
several possibilities for molecular and genetic characterization of this 
plant pathogen (8). Since then, some studies have expanded upon the 
knowledge we have about biological processes in Xac, mostly concern-
ing pathogenicity mechanisms (9–13). Recently, new tools for gene 
expression in Xac have been developed (14, 15), enabling studies on 
chromosome segregation and cell division. These cellular systems rep-
resent potential targets for antimicrobials, as the proteins involved 
in such processes share little homology with eukaryotic equivalents 
(16–19). Anti-Xac compounds that disrupt the localization of the cell 
division proteins ZapA and FtsZ in vivo, and that act on FtsZ in vitro, 
also affect localization of ParB (20, 21). Xac cells expressing truncated 
forms of ParB exhibit a filamentation phenotype (22). Inhibition of cell 
division in other bacteria like E. coli and B. subtilis leads to filamentation 
without chromosome segregation defects (23), suggesting a difference 
in the relation between cell division and chromosome segregation in Xac.
FtsZ is the central protein of the cell division machinery (23). At the 
start of cell division, FtsZ assembles a ring like structure at midcell 
called the Z ring. Z ring formation is followed by mid-cell constriction 
that generates two daughter cells. FtsZ is conserved among prokaryotic 
cells, yet different mechanisms have evolved in different bacteria that 
ensure that the Z ring assembles at midcell, at a specific time during the 
cell cycle, and does not constrict over the nucleoids. In the most studied 
gammaproteobacterium, Escherichia coli, Z ring localization is mediated 
by the Min system that consists of the proteins MinC, MinD, and MinE 
(24). MinC forms a complex with MinD to inhibit FtsZ function at the cell 
poles (25). The localization of MinC is mediated by MinD, which forms a 
Abstract
Xanthomonas citri (Xac) is the causal agent of citrus canker, a disease that 
affects citrus crops and causes economic impact worldwide. To further 
characterize cell division in this plant pathogen, we investigated the role 
of the protein MinC in cell division, chromosome segregation, and pepti-
doglycan incorporation by deleting the gene minC using allele exchange. 
Xac with minC deleted exhibited the classic Δmin phenotype observed 
in other bacteria deleted for min components: minicells and short fil-
amentation. In addition we noticed the formation of branches, which 
is similar to what was previously described for Escherichia coli deleted 
for either min or for several low molecular weight penicillin- binding 
proteins (PBPs). The branching phenotype was medium dependent and 
probably linked to gluconeogenic growth. We complemented the minC 
gene by integrating gfp-minC into the amy locus. Xac complemented 
strains displayed a wild-type phenotype. In addition, GFP-MinC oscil-
lated from pole to pole, similar to MinCD oscillations observed in E. coli 
and more recently in Synechococcus elongatus. Further investigation 
of the branching phenotype revealed that in branching cells nucleoid 


























































composition, and seems associated (or more prominent) with minimal 
media and the presence of casamino acids, and a disturbed localiza-
tion of the nucleoids (35). Branching increased in cells grown in the 
presence of low concentrations of beta-lactam antibiotics, indicating 
that interfering with PBP function increases this phenotype (34). This 
was confirmed in a series of papers from the Young laboratory, who 
observed a similar branching phenotype in E. coli deleted for several 
low-molecular-weight penicillin-binding proteins (LMW PBPs), most 
notably PBP5, the major DD-carboxypeptidase (36, 37). Branching most 
likely results from aberrant positioning of FtsZ and concomitant syn-
thesis of so-called “inert peptidoglycan” (iPG), which is not associated 
with cell division. iPG is consistently observed at the tips of branches 
and at branch sites (38–41).
2. Methods
2.1. Bacterial Strains and Growth Conditions
Bacterial strains and plasmids are listed in Table 1. Xac was cultivated 
at 30 °C in various media: nutrient yeast glycerol broth (NYGB, pep-
tone 5 g/L; yeast extract 3 g/L; glycerol 20 g/L) or on plates contain-
ing agar (15 g/L, NYGA) supplemented with D-glucose (1 % w/v) or 
L-arabinose (0.05 % w/v) when required; nutrient yeast citrate broth 
(NYCB, peptone 5 g/L; yeast extract 3 g/L; glycerol 2.46 g/L; Na3C6H5O7 
0.44 g/L); Xam1 medium (glycerol 2.46 g/L; MgSO4·7H2O 0.247 g/L; 
(NH4)2SO4 1.0 g/L; KH2PO4 4.5 g/L; K2HPO4 10.5 g/L; Na3C6H5O7·2H2O 
0.5 g/L; casamino acids 0.3 g/L; BSA 1 g/L; pH 5.4 adjusted with HCl); or 
Xamg1 medium which is identical to Xam1 except for glycerol which is 
at 20 g/L. LB 0 % is Lysogeny Broth without NaCl (tryptone 10 g/L; yeast 
extract 5 g/L), whereas LB 0.5 % contains NaCl 5 g/L.
For the cloning steps, we used E. coli DH10B (Invitrogen) cultivated 
in LB 0.5 %-agar/LB 0.5 % at 37 °C (42). The antibiotics kanamycin, gen-
tamicin, and ampicillin were used at the concentration of 20 µg/mL.
2.2. Construction of the replicative plasmid expressing 
Xac MinC 
The minC gene was amplified by PCR using Xac genomic DNA as a tem-
plate and the primers minC_pLAL1F/minC_pLAL1R (all oligonucleotides 
membrane-associated complex at one of the cell poles. MinE assembles 
at midcell in a ring like structure, and then cycles back and forth toward 
the cell poles stimulating the dissociation of the MinC/MinD complex. 
As soon as MinC/D dissociate from one of the poles, they are re-oriented 
to the opposite cellular pole in such a way that MinC, the FtsZ inhibitor, 
resides closer to the cellular poles far longer than it is in transit between 
them. This behavior creates a concentration gradient through the cell 
with MinCD lowest at midcell, which enables Z ring formation at this 
site (26). For a long time, MinCD oscillation had only been identified in E. 
coli, but recently it has also been observed in Synechococcus elongatus (27). 
Although inhibition of polar Z ring formation by MinCD is conserved 
in many bacteria, oscillation of MinCD seems restricted to bacteria that 
also contain MinE. In bacteria that do not have MinE, MinCD is anchored 
to the poles via other proteins such as DivIVA/MinJ (28).
Another mode of control of Z ring formation is the partially redun-
dant nucleoid occlusion system, in E. coli mediated by SlmA (29). SlmA 
binds to specific DNA sites and depolymerizes FtsZ, and this way the 
Z ring cannot assemble over a nucleoid (30). In several alphaproteo-
bacteria including the model organism Caulobacter crescentus, the DNA- 
binding protein ParB colocalizes with the edges of the nucleoids to drive 
chromosome segregation (22, 31). Then ParB forms a complex with 
MipZ, a FtsZ inhibitor that tracks along the ParB-chromosomal origin 
region (the bacterial centromere) in such a way that the inhibitory 
effect of MipZ will be concentrated at the cell poles and distal from the 
mid-cell where the divisional septum will be assembled (32).
Although Xac is a member of the gammaproteobacteria, in terms of 
chromosome segregation, it seems, at least mechanistically, related to 
C. crescentus and V. cholerae, as in these bacteria chromosome segregation 
is asymmetric. However, Xac does not have an obvious MipZ homolog. 
In terms of FtsZ regulation, Xac is closer to E. coli and V. cholerae, due 
to the presence of the Min system composed of the MinCDE proteins 
(33), although Xac doesn’t have an obvious SlmA homolog that could 
mediate nucleoid occlusion (22).
In this study, we have made a Xac mutant deleted for minC and ob-
served that this mutant not only forms minicells but also exhibits 
branching. This phenotype has also been described in E. coli deleted 
















































are listed Table S1). The resultant DNA fragment was digested with 
 EcoRI/HindIII and ligated into the Xac expression vector pLAL1 (Gen-
Bank KP696472; (46)) digested with the same enzymes, which resulted 
in pGCD1C.
2.3. Vector for Xac minC deletion 
Two DNA fragments flanking the genomic sequence of minC, minCup 
(870 bp), and minCdown (929 bp) were obtained by PCR using the 
primer pairs minCupF/minCupR and minCdownF/minCdownR, respec-
tively. The PCR products minCup and minCdown were digested with 
the restriction enzymes BamHI/XbaI and XbaI/HindIII, respectively, and 
ligated to pNPTS138 (kindly donated by Lucy Shapiro, Stanford Univer-
sity, USA) digested with BamHI/HindIII, which generated pNPTSΔminC.
2.4. Vector for GFP-fusions and gfp-minC vector
GFP-MinC was expressed using the integrative vector pGCD21, a deriv-
ative of pHF5Ca (22), , which enables the expression of GFP (gfp-mut1, 
GenBank ADF80258.1) fusion proteins in Xac under the control of 
the arabinose promoter. To construct pGCD21, gfp was removed from 
pPM7g (47) using the restriction enzyme BamHI/XbaI; the isolated gfp 
cassette was ligated to the backbone of pHF5Ca digested with the same 
enzymes, giving rise to pGCD19 (GenBank KJ619486). Next, the arabi-
nose repressor and promoter (araC-para) were amplified by PCR using 
pEB304 (45) as a template and the primer pair pARAF/pARAR. The PCR 
product was digested with EcoRI/BglII and ligated to the backbone of 
pGCD19/EcoRI/BglII, generating pGCD21 (GenBank KU678206). In 
order to clone Xac minC in pGCD21, the gene was isolated by PCR using 
genomic DNA and the primers minCF/201402minCR. The PCR product 
was digested with NotI/XbaI prior to ligation into pGCD21/NotI/XbaI, 
which resulted in pGCD2C.
All the constructs were checked by DNA sequencing. 
2.5. Xac minC gene deletion 
All plasmids were transformed in Xac by electrotransformation (48). 
First, Xac was transformed with the replicative vector pGDC1C, which 
provides an additional copy of minC. Afterwards, Xac/pGCD1C was trans-
formed with pNPTSΔminC, which mediates removal of chromosomal 
Table 1: list of strains and plasmids. 
Strains Relevant characteristics Reference
X. citri subsp. citri (Xac) Wild type strain 306 (Xac); ApR IBSBF-1594* (8, 
43, 44)
E. coli DH10B Cloning strain Invitrogen
Xac ∆minC Xac ∆minC; ApR This work
Xac amy::gfp Xac with pGCD21 integrated in amy; ApR KmR This work
Xac ΔminC amy::gfp Xac ΔminC with pGCD21 integrated in amy; 
ApR KmR
This work
Xac ΔminC amy::gfp-minC Xac ΔminC with pGCD2c integrated in amy; 
ApR KmR
This work
Xac amy::gfp-zapA Xac with pPM2a-ZapA integrated in amy; ApR 
KmR (former name: pPM2a-XAC3408)
(14)
Xac ΔminC amy::gfp-zapA Xac ΔminC with pPM2a-ZapA integrated in 
amy; ApR KmR
This work
Xac parB::parB-gfp Xac with pPM7g-parB integrated in parB; ApR 
KmR (former name: parB::pAPU3)
(22)




pPM2a and pPM7g GFP expression vectors; xylR pxyl gfpmut1 
bla neo
(14)
pAPU3 pPM7g-parB: xylR pxyl parB-gfpmut1 
bla neo
(22)
pHF5Ca TAP-tag expression vector; xylR pxyl tap1479 
bla neo
(22)
pEB304 pBAD derivative and source of the araC-para-
acp-tap1479 cassette; ApR
(45)
pNPTS138 Bacillus subtilis sacB gene; KmR; suicide vector 
in Xac
Prof. L. Shapiro 
(Stanford Univer-
sity, USA)
pGCD21 Derivative of pHF5Ca (22); araC-para-gfp-








pGCD1C Derivative of pLAL1; araC-para-minC; GmR; 
replicative vector in Xac 
This work
pGCD19 GFP expression vector; xylR pxyl gfpmut1 
ApR KmR
This work
pGCD2C Derivative of pGCD21; araC-para-gfp-
mut1-minC; amy106–912; ApR KmR
This work
ApR = ampicillin resistance, GmR = gentamicin resistance, KmR = kanamycin resistance, bla 



































































camera. Image analysis was performed using the software ImageJ 
(http://rsb.info.nih.gov/ij/).
Xac amy::gfp (wild type control) and Xac ΔminC amy::gfp were ana-
lyzed to observe MinC deletion effects. Xac ΔminC amy::gfp-minC was 
analyzed to see if GFP-MinC could complement the ΔminC phenotype. 
GFP producing strains were used as the cytosolic GFP allowed for an 
easier determination of whether a cell had divided or not. First, images 
were manually inspected for short filamentation, minicells and branch-
ing. Two biological replicates were analyzed with at least 200 cells 
each. Subsequently, cell lengths of rod-shaped cells (not minicells or 
branched cells) were measured using the public domain program Coli- 
Inspector, which runs under ImageJ in combination with the plugin 
ObjectJ, written by Norbert Vischer (http://simon.bio.uva.nl/objectj/). 
After the automatic selection process, a manual check was done to make 
sure only single cells were selected. Cells with a length equal to or longer 
than 3.15 µm were defined as short filaments. Two biological replicates 
of each strain were analyzed with at least 500 cells per replicate.
The nucleoid length in cells of Xac parB::parB-gfp and Xac ΔminC 
parB::parB-gfp stained with DAPI was manually measured using ObjectJ.
Xac amy::gfp-zapA and Xac ΔminC amy::gfp-zapA were were analyzed 
to observe co-localization of HADA (peptidoglycan incorporation) with 
GFP-ZapA (division sites), and possible MinC deletion effects. After the 
pictures were taken, the fluorescence channels CFP (HADA) and FITC 
(GFP-ZapA) were merged. Linescans were made of the cells displayed 
using the plot profile function of ImageJ. The maximum fluorescence in-
tensity of each cell was defined as 100 %, the minimum at 0 %, and plots 
were made relative to those levels (Figure S5). Linescans confirmed that 
colocalization could be scored manually from image overlays, which 
was done for a total of more than 100 cells per strain.
3. Results
3.1.  Xac deleted for minC displays a branching phenotype
To study the role of the Min system in Xac we deleted minC in a strain 
that expresses gfp. This resulted in a strain that exhibited the classical 
Δmin phenotype: next to rod-shaped cells of normal length, minicells 
and longer cells, both the result of polar divisions, could be observed 
minC by allele exchange. Mutant strains carrying one of the first cross-
over events (integration of pNPTSΔminC into minCup or minCdown) 
were selected on NYGA/kanamycin. To obtain the second crossover, 
deletion of minC, individual colonies were cultivated for 16 h in NYGB 
supplemented with 0.01 % arabinose and gentamycin only, which is 
the marker of pGCD1C. The final selection of Xac/pGCD1C ΔminC was 
carried out in NYGA supplemented with 3 % sucrose. Deletion of minC 
was verified by diagnostic PCR and Southern Blot experiments using 
minCD as a probe. To cure pGCD1C, Xac/pGCD1C ΔminC was cultivated 
for ~20 generations without gentamycin (Xac ΔminC).
Xac ΔminC was complemented with GFP-MinC by transformation 
with pGCD2C. The vector was stably integrated into the amy locus (Xac 
ΔminC amy::gfp-minC). For a GFP only control strain, Xac ΔminC was 
transformed with pGCD21. The vector was stably integrated into the amy 
locus (Xac ΔminC amy::gfp). To test whether GFP-MinC was expressed 
as full-length protein and not proteolytically cleaved inside the cell, 
cell extracts of cells expressing GFP only or GFP-MinC were analyzed 
by SDS-PAGE/Western Blot using antibodies against GFP (Figure S1).
2.6. Microscopy and data analysis.
Xac cells were grown to exponential phase in either NYGB or Xam1 
medium and directly imaged or labeled with a fluorescent dye prior 
to imaging. 
DAPI (4’,6-diamidino-2-phenylindole) was used to image DNA. Ex-
ponential phase cells were harvested, resuspended in 10 µM DAPI in 
Phosphate Buffered Saline (PBS) buffer, pH 7, for 30 min, washed twice 
in PBS and imaged.
HADA (Hydroxycoumarin-carboxylic acid-Amino-D-Alanine) label-
ing, to detect sites of peptidoglycan synthesis, was done as previously 
described by Kuru et al. (49). HADA was added to 125 µM in expo-
nential phase Xac cells, labeling time was 24 min in Xam1 or 10 min 
in NYGB (8 % of doubling time under these growth conditions). Cells 
were either imaged directly when simultaneous detection of GFP 
was required, or fixed with ice-cold ethanol for 10 min, and washed 
before imaging. 
Cells were imaged using a Nikon Ti-E microscope (Nikon Instru-
















































length analysis using Coli-inspector (methods). This showed that the 
length distribution of the minC deletion strain was a lot broader than 
that of the wild type and gfp-minC complemented strain (Figure S2). 
This is most likely because the longer cells in the minC deletion popu-
lation are the result of the outgrowth from an asymmetric division. It 
is impossible to precisely determine which cells are derived from an 
asymmetric division. Therefore, we defined “short filaments”, which 
are likely to represent such cells, as cells with a length of over 3.15 µm 
(this is 1.5 times the median length of cells in the wild type strain). 
These short filaments comprised around 16 % of the cells observed in 
the minC deletion strain, whereas the wild type strain, and the strain 
complemented with gfp-minC had less than 3 % of these cells. As the gfp-
minC complemented strain is so similar to the wild type, while the minC 
deletion is strikingly different, and as GFP-MinC does not show signs of 
degradation even when overexpressed (Figure S1), we conclude that 
GFP-MinC is fully functional.
3.2. MinC is localized at the poles and oscillates from pole 
to pole
The strain Xac ΔminC amy::gfp-minC, in which gfp-minC is the only copy 
of minC, was studied using fluorescence microscopy. As expected, GFP- 
MinC was localized in a gradient throughout the cell with the maxi-
mum at one of the poles (Figure 2). To see whether MinC oscillates 
from pole to pole, as previously described for E. coli and recently for S. 
elongatus (27), we imaged the cells with 10 s intervals. These short time 
lapses clearly show that GFP-MinC localization is dynamic, and that the 
(Figure 1B; b, c). However, in addition to these phenotypes, branched 
cells were also observed in the minC mutants (Figure 1B; a). Similar 
results were obtained in a strain that did not carry a copy of the gfp 
gene (Figure 1D). To show that the phenotype was due to the deletion 
of minC, and not caused by any polar effects, we complemented the 
strain with gfp-minC at the ectopic amy locus. This complementation 
restored the wild type phenotype (Figure 1C, Table 2).
Branches and minicells were not observed in the wild type strain 
nor in the strain complemented with gfp-minC. Branches and minicells 
could not be detected automatically, thus the frequency of their occur-
rence in the minC deletion strain was scored by visual inspection, which 
revealed that around 20% of the cells were either minicells or branched 
cells (Table 2, see Section Branching in the minC Deletion Strain is 
Dependent on Growth Medium for more details on branching). Subse-
quently, the length of the rod-shaped cells was determined by automatic 
Figure 1: Phase contrast images showing the morphology of Xac strains grown to ex-
ponential phase in Xam1 medium. (A) Xac amy::gfp. (B) Xac ΔminC amy::gfp with (a) 
branching, (b) minicells, and (c) short filamentation. (C) Xac ΔminC amy::gfp-minC. (D) 
Xac ΔminC with (a) branching, (b) minicells, and (c) short filamentation. Scale bar: 1 μm.
Table 2: Phenotype observations in different strains.
Strain Minicells Branching Short  Filaments1 Normal Total
Xac amy::gfp ND2 ND2 1.4 ± 0.6 % 98.6 ± 0.6 % 1599
Xac ΔminC amy::gfp 7.3 ± 2.5 % 12.9 ± 2.7 % 16.0 ± 2.9 % 63.8 ± 3.0 % 424
Xac ΔminC 
amy::gfp-minC
ND2 ND2 1.9 ± 1.6 % 98.1 ± 1.6 % 1624
1Cells with length ≥ 3.15 µm; 2Not detected.
Figure 2: Xac ΔminC amy::gfp-minC grown to exponential phase in Xam1 medium. (A) 
phase contrast showing phenotype similar to wild-type. (B) FITC showing GFP-MinC 

























































medium. Some branching was observed on rich (LB) medium, whereas 
growth on minimal salt (M9) media supplemented with casaminoacids 
and either succinate or acetate, but not glucose, resulted in branching in 
5 % to 20 % of the cells depending on the E. coli strain studied (34, 35). We 
tested the medium dependency of the branching phenotype of the Xac 
minC deletion strain and observed similar results: hardly any branches 
on the rich NYG/CB media and roughly 12 % of branches on the minimal 
salt Xam1 medium. An intermediate phenotype was observed on LB 
where cells showed bulges and abnormal extensions at the poles. These 
cells were scored as branching cells (Table 3; Figure 4). We would like 
to remark that it is formally possible that minicells do not only originate 
protein oscillates from pole to pole (Figure 3, Video 1 (50)). Following 
several oscillations in various cells over time revealed that GFP-MinC 
oscillates with a periodicity of roughly 65 s, which is comparable to the 
oscillations described in E.coli (51). 
3.3. Branching in the minC deletion strain is dependent 
on growth medium
The branching phenotype of E. coli min mutants has been described in 
two studies from the 1990’s (34, 35), but the phenotype, to paraphrase 
a paper from the Young lab, has received much less attention than 
other questions related to bacterial morphology (41). Branching of min 
mutants was shown to be dependent on the composition of the growth 
Figure 3: Xac ΔminC amy::gfp-minC, contrast (inset), and FITC time lapse. Triangles 
indicate cell poles showing MinC oscillation pattern. Scale bar 1 μm.
Table 3: Xac ΔminC amy::gfp phenotypes in different media.
Medium Minicells Branching Short Filaments Normal Total
Xam1 7.3 ± 2.5 % 12.9 ± 2.7 % 16.9 ± 2.9 % 63.8 ± 3.0 % 424
Xamg1 16.3 ± 4.0 % 18.0 ± 5.6 % 13.4 ± 4.4 % 52.4 ± 6.1 % 401
LB 0 % 11.6 ± 1.6 % 6.9 ± 0.4 % 18.8 ± 0.6 % 62.8 ± 4.2 % 262
LB 0.5 % 11.6 ± 1.3 % 8.7 ± 3.4 % 17.2 ± 1.7 % 68.4 ± 9.5 % 387
NYCB 12.4 ± 2.2 % 0.78 ± 0.03 % 17.4 ± 2.2 % 69.5 ± 2.3 % 387
NYGB 11.7 ± 3.4 % 1.4 ± 1.9 % 15.3 ± 3.5 % 71.6 ± 1.2 % 488
Figure 4: Phase contrast images showing branching of Xac ΔminC amy::gfp grown to 
exponential phase in different media. (A) Xam1. (B) Xamg1. (C) LB 0 %. (D) LB 0.5 %. 

























































relation between cell division site placement and peptidoglycan synthe-
sis by using GFP-ZapA (14) as a proxy for division site localization and 
from polar divisions but also from budding of branches. However, as 
the frequency of mini cell formation under non-branching conditions 
is almost the same as on branching conditions we deem this unlikely.
3.4. Nucleoid organization in the Xac minC deletion 
strain
Disruption of the min system in E. coli (52, 53) results in aberrant nu-
cleoids, and in the case of branching cells large masses of DNA are 
often located at branching points (35). To study nucleoid distribution 
and organization we made use of strains carrying a functional GFP 
fusion to ParB (22). In a wild type background, GFP-ParB localizes to 
the origin- proximal parS site on the chromosome. Upon parS dupli-
cation during chromosome replication and segregation, ParB bound 
to the second parS copy moves from one pole to the other during the 
cell cycle (22) (Figure 5). We introduced the parB-gfp allele into the 
ΔminC background to construct the strain Xac ΔminC parB::parB-gfp, 
and studied nucleoid distribution with DAPI and nucleoid organization 
using ParB-GFP. In branching cells, we observed longer nucleoid length 
and the occasional accumulation of DNA at branch points (Figure 5B; 
Figure 6), although the accumulation at branch points was not a typical 
feature of branching cells (9 out of 36 branching cells on Xam1 had 
DNA at the branch point). The ParB-GFP pattern appeared less clearly 
defined on Xam1 medium (Figure 5A, B) with more faint fluorescent 
spots visible in the cells compared to the one or two spots per cell seen 
with NYGB medium (Figure 5C, D).
3.5. Branching cells have deficiencies in positioning cell 
division and peptidoglycan synthesis
In E. coli, branch formation is the result of defects in positioning the cell 
division machinery, notably FtsZ (41). In min mutants the FtsZ ring can 
form at the poles, but there is also an increased zone for FtsZ polymer-
ization at midcell, which also occurs in cells with defective PBP5 (41). 
In E. coli some peptidoglycan (PG) is synthesized in an FtsZ- dependent 
manner at a site that will form the new pole, and strikingly this PG is not 
subject to turnover of material, which is why it is called inert PG (iPG) 
(54). iPG is always found at the poles and at the tips of branches, which 
originate from places on the side wall that contained iPG. We studied the 
Figure 5: (A) Xac parB::parB-gfp grown in Xam1. (B) Xac ΔminC parB::parB-gfp grown 
in Xam1. (C) Xac parB::parB-gfp grown in NYGB. (D) Xac ΔminC parB::parB-gfp grown in 
NYGB, triangles indicate divisions initiated over non-segregated nucleoids. All cells in the 
figure were labeled with DAPI. Phase contrast (left), DAPI (center) exhibiting nucleoids, 

























































the fluorescent D-amino acid analog HADA (55) to label sites of active, 
ongoing PG synthesis. Cells were grown for 24 min (8 % of the doubling 
time) in the presence of HADA and analyzed. In wild type cells, most 
PG synthesis occurred at division sites at midcell, which could also be 
identified by fluorescent bands of GFP-ZapA (Figure 7A, C). This pattern 
is similar to HADA labeling in other rod-shaped bacteria such as E. coli 
and B. subtilis (55). Sometimes, spots of HADA were seen at some poles, 
which could be due to the fact that the HADA was incorporated in the 
septum just before cell division. In non-dividing cells, GFP-ZapA local-
ized throughout the cytosol as described (14). Sometimes, spots of HADA 
were seen at some poles, which could be due to the fact that the HADA 
was incorporated in the septum just before cell division. In non-dividing 
cells, GFP-ZapA localized throughout the cytosol as described (Table 4). 
In the minC deletion mutant, this colocalization of GFP-ZapA and HADA 
incorporation at division sites was lost (Figure 7B, D, Table 4). The 
Figure 6: Nucleoid length of Xac cells, with and without MinC, grown to exponential 
phase in Xam1 medium, measured manually with ObjectJ. Whiskers at the top represent 






Figure 7: (A) Xac amy::gfp-zapA grown to exponential phase in Xam1, labeled with 125 µM 
of HADA for 24 min. (B) Xac ΔminC amy::gfp-zapA grown to exponential phase in Xam1, 
labeled with 125 µM of HADA for 24 min. (C) Xac amy::gfp-zapA grown to exponential 
phase in NYGB, labeled with 125 µM of HADA for 10 min. (D) Xac ΔminC amy::gfp-zapA 
grown to exponential phase in NYGB, labeled with 125 µM of HADA for 10 min. Phase 
contrast (left). FITC (center) exhibiting GFP-ZapA at the septum. CFP (right) exhibiting 




































































The Min system is responsible for ensuring that the cell division ma-
chinery assembles at the right place; this goal is achieved by negative 
regulation of FtsZ by MinC (61). The absence of MinC creates more 
space for Z rings to assemble, both at the poles of cells and at midcell, 
resulting in the formation of minicells, the characteristic phenotype 
of min mutants. The presence of other regulatory systems, such as nu-
cleoid occlusion and the composition of the cell wall, generally confine 
Z rings at midcell sufficiently to ensure “normal” divisions, perpendic-
ular to the length of the cell, but under certain conditions branches can 
start to form. Branching is thought to arise from a disruption in the 
organization of Z rings in such a way that Z rings are allowed to form 
in more places and at unnatural angles. This is in line with the obser-
vation that branching in E. coli is exacerbated upon overexpression of 
ftsZ (41), as higher levels of FtsZ result in the formation of abnormal 
rings in multiple bacteria. Branching of min mutants of E. coli does not 
always occur — but seems to be dependent on growth conditions and 
correlated with the general physiology of the cell rather than specific 
media components (34). We have observed a similar, growth condition 
dependent, branching phenotype in Xac.
Several papers in the past decade have pointed to a role for metabo-
lism in the control of cell division and shape (56). For example, Z ring 
formation is directly controlled in E. coli and B. subtilis by two differ-
ent metabolic enzymes that moonlight as FtsZ inhibitors (62). In vitro 
evidence points to UDP-glucose as the molecule responsible for the 
metabolic control but an (additional) role for increased levels of pepti-
doglycan precursors in triggering enhanced division is possible (56). In 
addition, pyruvate dehydrogenase E1α (PDH E1α) has been identified as 
a positive regulator of FtsZ ring formation in B. subtilis, which links the 
presence of high levels of pyruvate to increased division at midcell (57). 
High levels of pyruvate are linked to a high glycolytic flux and a switch 
to gluconeogenic conditions has implications for the availability of cell 
wall precursors and FtsZ positioning (57). In this respect it is interesting 
to note that the general physiology in which branching occurs most in 
the min mutants in both E. coli (34) and Xac is gluconeogenic growth. 
A branching phenotype is a common feature among asymmetric 
polar growing bacteria (63), such as in Actinomycetes, Rhizobiales and 
Caulobacterales (64). Here, branching is caused by dedicated proteins, 
minC deletion strain when grown in conditions that promote branching, 
shows less complete GFP-ZapA rings, which also do not appear to be 
fully perpendicular to the cell axis, and strong GFP-ZapA signals are 
not overlapping with bands of HADA that can be observed at sites that 
show constrictions that would be indicative of ongoing divisions. When 
these cells are grown under non-branching conditions, this defect in 
colocalization of GFP-ZapA and HADA was not rescued (Table 4). Recent 
work has pointed at a role for metabolism in the control of cell division, 
with pyruvate levels in B. subtilis stimulating efficient Z ring formation 
under nutrient rich conditions through pyruvate dehydrogenase E1α 
(56, 57). We tested whether the addition of pyruvate to the medium in 
which branching occurs can rescue Z ring positioning and branching, 
but this was not the case (Figure S3).
4. Discussion
In this work, we have shown that MinC oscillates from pole to pole to 
ensure proper cell division and cell shape in Xac. Although the oscilla-
tion of MinCD was described nearly 20 years ago (51, 58), it was only 
last year that the second and third cases of oscillating Min proteins in 
the homologous host were described in S. elongates (27), and V. cholera 
(33). Our observation of GFP-MinC oscillations in Xac now provides 
the fourth example. Oscillations of Min system proteins have also been 
reported in heterologous systems. For example, MinDE from Neisseria 
gonorrhoeae have been shown to oscillate when expressed in E. coli (59), 
and MinDE from Clostridium difficile have been shown to oscillate when 
expressed in B. subtilis (60). Combined, these reports support the idea 
that an oscillating Min system is a common feature as long as the Min 
system protein MinE is present.
Table 4: Overlapping events in pictures of cells with HADA and GFP-ZapA signals.
Strain Medium Overlap No overlap Total
Xac amy::gfp-zapA Xam1 97 % (101) 3 % (3) 100 % (104)
Xac ∆minC amy::gfp-zapA Xam1 18 % (25) 82 % (114) 100 % (139)
Xac amy::gfp-zapA NYGB 73 % (76) 27 % (28) 100 % (104)































































it is probably not caused by the effect of the media on GFP as GFP-ZapA 
did not show such a difference.
In conclusion, we have shown that Xac min mutants display a me-
tabolism-dependent branching phenotype which is the result of delo-
calized cell division and peptidoglycan synthesis. Also, we have shown 
that MinC oscillation occurs in a third organism next to E. coli and 
S. elongatus.
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not aberrantly positioned Z rings (65). In E. coli, positioning of FtsZ not 
exactly at midcell can result in the synthesis of inert PG that will form 
the future tip of a branch. We studied the relation between cell division 
and PG synthesis in the branching min mutants of Xac. We used the 
fluorescent D-amino acid analog HADA, which can be used to track PG 
synthesis in many different bacteria (55), to establish that wild type 
Xac grows similar to other rod-shaped bacteria, with PG incorporated 
both at the lateral wall and at division sites. In wild type cells, PG syn-
thesis at division sites and visible GFP-ZapA rings clearly overlapped. 
In the branching minC mutant, these patterns were lost. Cell division 
was clearly impaired as shown by the scattered localization of ZapA 
patches that often did not form perpendicular rings that would support 
division, and scattered HADA incorporation. Interestingly, the ZapA 
and HADA localization patterns hardly overlapped in the minC mutant, 
something one would expect if the aberrant placement of division sites 
would recruit PG synthesis enzymes. 
Potluri et al. (41) observed similar branching formation in E. coli cells 
deleted for PBP5 and other low molecular weight penicillin-binding 
proteins (PBPs). They proposed a link between branching formation and 
aberrant cell division. In the absence of PBPs, and PBP5 in particular, 
the organization of Z rings is disturbed in such a way that they are 
allowed to form in more places and at unnatural angles. This leads to 
malformation of daughter cells, which leads to branching phenotypes. 
Our observations of GFP-ZapA and HADA incorporation demonstrate 
that the minC deletion in Xac leads to disruption of both cell division 
and peptidoglycan incorporation, but the effects on Z-ring placement 
seem more drastic compared to the E. coli phenotype. However, it is 
likely that the disruption of division site placement and peptidoglycan 
incorporation result in similar branching of daughter cells as previously 
reported for E. coli (41).
Finally, we observed that similar to E. coli min mutant branching cells, 
Xac min mutants that branch, show disorganization of the nucleoids. 
Whether this is a result of the deformation of the cells only, or whether 
the Min system influences asymmetric chromosome segregation in Xac 
we cannot say. We noticed that ParB-GFP localized in clear spots in cells 
grown on NYGB medium, whereas the localization pattern was more 
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Figure S1: Western blot with cells grown in Xam1 with 2 % glucose using Rabbit polyclonal 
GFP1 antibody. Secondary antibody detection was done using the Amersham ECL kit.
1 Molecular weight ladder; 2 Xac amy::gfp-minC; 3 Xac amy::gfp-minC + arabinose1; 4 Xac 
ΔminC amy::gfp; 5 Xac ΔminC amy::gfp + arabinose1; 6 Xac ΔminC amy::gfp-minC; 7 Xac 
ΔminC amy::gfp-minC + arabinose1; 
1G1544 from SIGMA diluted 1:2500.
20.05 % arabinose during 1 h.
Figure S2: (A) Cell length of Xac amy::gfp (n = 1599), Xac ΔminC amy::gfp (n = 1114) and 
Xac ΔminC amy::gfp-minC (n = 1624), grown to exponential phase in Xam1 medium. (B) 
Cell length of Xac amy::gfp (n = 729), Xac ΔminC amy::gfp (n = 589) and Xac ΔminC amy:: gfp-
minC (n = 551), grown to exponential phase in NYGB medium. Both sets were measured 
automatically with Coli-Inspector, plugin for ObjectJ. Whiskers at the top represent the 
1.5 interquartile range and whiskers at the bottom extend to the minimum value.
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Figure S3: Xac ΔminC amy::gfp grown to exponential phase in NYGB medium diluted to 
Xam1 medium and then grown overnight. (A) without sodium pyruvate. (B) with 1 % 
sodium pyruvate. Scale bar: 1 µM.
Figure S4: Line scans showing relative fluorescence intensity of FITC channel (GFP-
MinC) along the central axis of Xac ΔminC amy::gfp-minC cells grown to exponential 
phase in Xam1 medium.








































































































































































































































































Table S1: Oligonucleotides used in this study. 
Name Sequence










minCupF (BamHI) 5’- AAAGGATCCGTATGACTGAGGTATCCCAACATGTC 
minCupR (XbaI) 5’- AAATCTAGATGCCACAACTCAGCTCCCCGTCGATG
minCdownF (XbaI) 5’- AAATCTAGAGATTGACGCGGCCCAACCACAGAAATATTC
minCdownR (HindIII) 5’- AAAAAGCTTCAATGATGATCTGCAGGCGGTTCTTGG
Video 1 can be downloaded at:
https://www.frontiersin.org/articles/10.3389/fmicb.2017.01352/full#supplementary- 
material
Chapter 5 — Summary













The compound was tested on two multidrug resistant bacteria, meth-
icillin resistant Staphylococcus aureus and Vancomycin resistant Entero-
coccus faecium, and it was able to kill those multidrug resistant strains 
at the same concentration as drug sensitive strains. This suggested 
that 7b-BF4 possesses a different mode of action when compared to 
the antibiotics to which those organisms are resistant.
Bacillus subtilis was used as a model organism to determine whether 
7b-BF4 disrupted the membrane permeability. Membrane permeability 
was investigated using a combination of the membrane permeable and 
membrane impermeable dyes (SYTO 9 and propidium iodide, respec-
tively). This was followed by an investigation whether 7b-BF4 disrupts 
the membrane potential in B. subtilis using the potentiometric probe 
DiSC3. 7b-BF4 does not disrupt membrane potential. The effect of this 
compound on the four major metabolic pathways (DNA, RNA, protein, 
and peptidoglycan synthesis) of B. subtilis was tested using precursors 
labelled with 3H. 7b-BF4 affected all the four pathways without indi-
cation of a pathway specific effect. 7b-BF4 causes a sharp decrease in 
intracellular ATP concentration in B. subtilis, which is likely the reason 
the four metabolic pathways were affected. Development of resistance 
against 7b-BF4 was stimulated in the lab growing B. subtilis under 
sublethal concentrations of the compound for an extended period of 
time, but resistance was not detected.
The results obtained in this chapter showed that 7b-BF4 is a strong 
antimicrobial agent against Gram-positive bacteria. While the exact 
mode of action of this compound is still unknown, our work indicates 
that it is different from other known antibiotics. Our suggestions for 
further characterizing the mode of action of this compound in the 
future are: RNA sequencing of cells under stress caused by the com-
pound; electron microscopy of cells in the presence of the compound, 
since the compound contains gold it should be possible to detect its 
localization; and further stimulation of resistant mutants followed by 
genomic analyses of detected mutants.
The second experimental report of this thesis (Chapter 3), presents 
an investigation into the mode of action of the chalcones BC1 and T9A. 
Those chalcones were synthesized by our collaborators in Brazil, that 
have a particular interest in combating the Gram negative bacteria 
Xanthomonas citri subsp. citri (Xac), the agent of citrus canker (Ayusso 
Summary
Bacteria are the most ubiquitous organisms on Earth. In a human body, 
there are more bacterial cells than human cells (1). Among other func-
tions, these microorganisms are responsible for fixation of nitrogen 
from the atmosphere in soils, which enables the survival of complex 
terrestrial life (i.e., plants and animals) (2). The metabolic diversity 
of bacteria has been harnessed for the synthesis of industrial com-
pounds such as pharmaceuticals, food ingredients and additives, and 
biocatalysts (3). However, a small proportion of bacteria are pathogenic, 
causing damage to agriculture and humans (4). To combat these bac-
teria, humans have developed antibiotics and antimicrobials, which 
drastically reduced mortality from bacterial diseases and increased 
human life expectancy worldwide (5).
The widespread use of antibiotics stimulated antibiotic resistance 
(6), which has rapidly become a danger to public health. More than 
700 000 human deaths worldwide a year are caused by antimicrobial 
resistance (7), and this figure is likely to increase in the future (8). 
Antibiotics and antimicrobial compounds such as copper are also used 
in agriculture to combat plant pathogens (9–13). The use of antimicro-
bials in agriculture reduces the loss of crops due to field diseases and 
increases the yield of food production. However, increasing antimicro-
bial resistance in phytopathogens is also a threat to agriculture (14).
So far the discovery of antibiotics has managed to keep human 
pathogens under control (15). The discovery of new antibiotics is 
needed to avoid a widespread pandemic of antibiotic resistant bacte-
ria (16). In a similar manner, new antimicrobials are also needed to 
combat plant diseases more effectively (Chapter 1). Once discovered 
and characterized for their mode of action, antimicrobial substances 
can be chemically modified to improve potency, stability, delivery, or 
pharmacokinetics. This strategy has resulted in the development of 
dozens of new clinically useful antibiotics (17).
The first experimental chapter of this thesis (Chapter 2) is about 
the screening of organometallic compounds, and characterization of 
the antimicrobial activity of the compound 7b-BF4. Those compounds 
were synthesized with the primary idea of developing gold-based 
anticancer drugs. 7b-BF4 exhibited the highest antimicrobial activity 
























have been found to have activity against Xac, inactivating cells in the 
lab and preventing infection on citrus leaves (25). The antimicrobial 
activity of alkyl gallates was characterized in B. subtilis, because at that 
time, FtsZ from Xac had not been purified yet and membrane perme-
ability assays were not available for Xac (26). This appendix contains 
my contributions to the work of our group on the characterization of 
the antimicrobial activity of alkyl gallates against Xac (27).
In this work we tested the activity of alkyl gallates on Xac mem-
branes, which in combination with our colleagues’ results, showed 
that the primary antimicrobial activity of alkyl gallates on Xac is on 
the membrane permeability. In an attempt to address the susceptibility 
to resistance, we tried to develop the resistance of Xac against heptyl 
gallate (the most effective alkyl gallate on pathogenicity test (25)). Xac 
developed resistance against our positive control kanamycin, but not 
against heptyl gallate in the same experimental setting. On the one 
hand, this result eliminated the possibility of sequencing and studying 
resistant mutants in order to further characterize the mode of action of 
the compound, on the other hand this is an indication that resistance 
against this compound is less likely to occur which increases its appeal 
as an antimicrobial agent. Additionally, the same setting can be used in 
future studies on mode of action of compounds against Xac.
The last experimental chapter of this thesis (Chapter 4) focuses on 
the cell biology of Xac. In this chapter we engineered a strain of Xac with 
the gene minC deleted. This gene encodes the MinC protein, part of the 
Min system that in Xac (as well as in the thoroughly studied bacteria 
E. coli) consists of the MinC, MinD, and MinE proteins (28). This system 
is responsible for the spatial regulation of cell division, ensuring that 
it happens at mid cell and not at a random site along the rod shaped 
bacteria (e.g. at the cell poles). In E. coli this is possible because MinC 
forms a complex with MinD, thereby preventing the Z-ring to assemble 
in its vicinity. MinE activity causes the MinCD complex to oscillate 
between cell poles, therefore FtsZ is driven away from the poles and 
assembles at mid cell (29).
We investigated cell division, chromosome segregation, and pep-
tidoglycan incorporation in wild type and ΔminC mutants. The gene 
minC was deleted using allele exchange. Xac with minC deleted exhib-
ited minicells, short filamentation, and branching. The minC gene was 
et al., in preparation). Nearly all citrus species are susceptible to citrus 
canker, and there are no effective ways of eliminating Xac from an 
infected plant, leading to the eradication of infected trees (18). Brazil 
is the biggest orange producer in the world and the orange industry is 
negatively affected by citrus canker (19).
Naturally occurring chalcones are usually not active against Gram neg-
ative bacteria (20, 21), but those compounds can be chemically modified 
to target Gram negative bacteria (22, 23). T9A was the result of a screen-
ing made by our colleagues, that synthesized chalchones with substituted 
by hydroxyl group (hydroxychalcones) (Ayusso et al., in preparation). 
T9A was selected for this study because it was the most active drug on 
that screening (Ayusso et al., in preparation). BC1 is a methoxychalcone 
obtained from the molecular simplification of curcumin (24). 
The effect of BC1 and T9A on membrane permeability was tested 
using a combination of the membrane permeable and membrane imper-
meable dyes, in B. subtilis and Xac and T9A does not disrupt membrane 
permeability whereas BC1 disrupts B. subtilis membranes and does not 
disrupt Xac membranes. The effect of BC1 and T9A on four the major 
metabolic pathways (DNA, RNA, protein, and peptidoglycan synthesis) 
in B. subtilis and Xac, using the same precursors, labelled with 3H. This 
chapter, to our knowledge, is the first report of metabolic pathways 
assays on Xac. We also tested the effect of BC1 and T9A on intracellular 
ATP concentration in B. subtilis and Xac. Similarly to what was observed 
in chapter 2, the chalcones affected all the four macromolecular path-
ways. However, ATP concentration was not affected by the compounds 
in B. subtilis and little impact was observed in Xac. Fourier-transform 
infrared (FTIR) spectrophotometry with B. subtilis treated with the 
chalcones was consistent with membrane disruption by BC1, but in-
conclusive for T9A. FTIR was not successful in Xac due to the formation 
of xanthan gum and biofilms.
The data produced in this chapter do not allow us to draw a conclusion 
about a specific mode of action of the compounds tested. However, we 
were able to generate Xac strains with resistance to T9A and BC1, which 
opens the possibility to sequence and carry out genomic analyses to 
understand the mode of action of this compounds.
This chapter is followed by an appendix where our results on the 


























Bacteriën zijn de meest alomtegenwoordige organismen op aarde. In een 
menselijk lichaam zijn er meer bacteriële cellen dan menselijke cellen 
(1). Deze micro-organismen zijn, onder andere, verantwoordelijk voor 
de fixatie van stikstof uit de atmosfeer in de bodem, wat het overleven 
van complexe aardse levensvormen (d.w.z. planten en dieren) mogelijk 
maakt (2). De metabolische diversiteit van bacteriën wordt gebruikt 
voor de synthese van industriële verbindingen zoals farmaceutische 
producten, voedselingrediënten, additieven en biokatalysatoren (3). 
Sommige soorten bacteriën zijn echter pathogeen en veroorzaken 
schade aan de landbouwsector en de volksgezondheid (4). Om deze 
bacteriën te bestrijden, zijn er antibiotica en antimicrobiële middelen 
ontwikkeld. Deze middelen hebben de sterfte aan bacteriële ziekten 
drastisch verminderd en hebben wereldwijd de levensverwachting 
van mensen verhoogd (5).
Het wijdverbreide gebruik van antibiotica stimuleerde de ontwikkeling 
van antibioticaresistentie in bacteriën (6), die in een rap tempo een ge-
vaar voor de volksgezondheid is geworden. Jaarlijks worden wereldwijd 
meer dan 700 000 menselijke sterfgevallen veroorzaakt door antimi-
crobiële resistentie (7), en dit cijfer zal in de toekomst waarschijnlijk 
toenemen (8). Antibiotica en antimicrobiële stoffen zoals koper worden 
ook in de landbouw gebruikt om plantpathogenen te bestrijden (9–13). 
Het gebruik van antimicrobiële middelen in de landbouw vermindert 
het verlies van gewassen als gevolg van veldziekten en verhoogt de 
opbrengst van voedselproductie. De concurrente ontwikkeling van 
antimicrobiële resistentie bij fytopathogenen vormt echter ook een 
bedreiging voor de landbouwsector (14).
Tot nu toe is de ontdekking van antibiotica er grotendeels in geslaagd 
om menselijke ziekteverwekkers onder controle te houden (15). Echter 
is de ontdekking van nieuwe antibiotica nodig om een  wijdverspreide 
pandemie van antibioticaresistente bacteriën te voorkomen (16). Op 
vergelijkbare wijze zijn ook nieuwe antimicrobiële middelen nodig 
om plantenziekten beter te bestrijden (Hoofdstuk 1). Na ontdekking 
kunnen antimicrobiële stoffen chemisch worden gemodificeerd om de 
complemented by integrating gfp-minC into the amy locus. Complement-
ed Xac strains displayed a wild-type phenotype. In addition, GFP-MinC 
oscillated from pole to pole, similar to MinCD oscillations observed 
in Escherichia coli and more recently in Synechococcus elongatus (30) 
and Vibrio cholerae (31). Thus, oscillating MinC seems to be a common 
feature among bacteria with the minE gene. Further investigation of 
the branching phenotype revealed that, in branching cells nucleoid 
organization, divisome formation, and peptidoglycan incorporation 
were disrupted, and that peptidoglycan incorporation was uncoupled 
from divisome formation in branching cells. The branching was also 
nutrient dependent and was rescued in medium containing peptone.
With this thesis we attempted to open new possibilities for studying 
both the cell biology of Xac and the mode of action of antimicrobial 
compounds. The radiolabel assay to test specific metabolic pathways, 
fluorescence assays to test membrane permeability, membrane po-
tential, and peptidoglycan incorporation, fluorescent protein fusions 
with ZapA, MinC, and ParB, and FtsZ assays used in this thesis are a 
fine addition to a tool set to test new antimicrobials with potential to 
combat citrus canker and other infections. Genomic analyses of resis-
tant mutants and RNA sequencing of cells treated with compounds are 
possibilities to expand our tool set and to establish the mode of action 














een langere tijdsperiode te kweken, er werd echter geen ontwikkeling 
van resistentie gedetecteerd.
De resultaten die in dit hoofdstuk zijn verkregen, hebben aangetoond 
dat 7b-BF4 een sterk antimicrobieel middel tegen Gram-positieve bac-
teriën is. Hoewel de exacte werkingswijze van deze stof nog onbekend 
is, geeft ons werk aan dat het anders is dan de werkwijze van andere 
bekende antibiotica. Onze suggesties voor het verder karakteriseren van 
de werkingswijze van deze verbinding in de toekomst zijn: RNA-sequen-
cing van cellen onder stress veroorzaakt door de verbinding; elektro-
nenmicroscopie van cellen in de aanwezigheid van de verbinding, omdat 
de verbinding goud bevat, zou het mogelijk moeten zijn de lokalisatie in 
de cel ervan te detecteren; en verdere stimulatie van resistente mutan-
ten gevolgd door genomische analyses van gedetecteerde mutanten.
Het tweede experimentele rapport van dit proefschrift (Hoofdstuk 3) 
presenteert een onderzoek naar de werkingswijze van de chalconen BC1 
en T9A. Deze chalconen werden gesynthetiseerd door onze medewer-
kers in Brazilië, die een bijzondere interesse hebben in het bestrijden 
van de Gram-negatieve bacterie Xanthomonas citri subsp. citri (Xac), de 
biologische agens die citruskanker veroorzaakt (Ayusso et al., in voorbe-
reiding). Bijna alle citrus soorten zijn gevoelig voor citruskanker en er 
zijn geen effectieve manieren om Xac uit een geïnfecteerde plant te ver-
wijderen, waardoor geïnfecteerde bomen gerooid moeten worden (18). 
Brazilië is de grootste sinaasappel producent ter wereld en de sinasappel 
industrie ondervind schade door citruskanker (19). Natuurlijk voor-
komende chalconen zijn gewoonlijk niet actief tegen Gram-negatieve 
bacteriën (20, 21), maar deze verbindingen kunnen chemisch worden 
gemodificeerd om toch actief te worden tegen Gram-negatieve bacteri-
en (22, 23). Verbinding T9A was het resultaat van een screening door 
onze collega’s, die chalchonen met gesubstitueerde hydroxylgroepen 
(hydroxychalconen) synthetiseerden (Ayusso et al., In voorbereiding). 
Verbinding T9A werd geselecteerd voor deze studie omdat het de meest 
actieve verbinding in die screening was (Ayusso et al., In voorbereiding). 
Verbinding BC1 is een methoxychalcon verkregen uit de moleculaire 
versimpeling van curcumine (24).
potentie, stabiliteit, levering of farmacokinetiek te verbeteren. Deze 
strategie heeft geresulteerd in de ontwikkeling van tientallen nieuwe 
klinisch bruikbare antibiotica (17).
Het eerste experimentele hoofdstuk van dit proefschrift (Hoofdstuk 2) 
gaat over de antimicrobiële screening van organometallische verbin-
dingen en de karakterisatie van de antimicrobiële activiteit van de 
verbinding 7b-BF4. De verbindingen besproken in dit werk werden 
gesynthetiseerd met het doel om op goud gebaseerde middelen tegen 
kanker te ontwikkelen. 7b-BF4 vertoonde de hoogste antimicrobiële 
activiteit tegen Gram-positieve bacteriën onder de gescreende ver-
bindingen. De verbinding 7b-BF4 werd getest op twee multiresistente 
bacteriën, methicilline-resistente Staphylococcus aureus en Vancomy-
cineresistente Enterococcus faecium en het was in staat om die mul-
ti-geneesmiddelresistente stammen te doden bij dezelfde concentratie 
als geneesmiddel-gevoelige stammen. Dit suggereerde dat 7b-BF4 een 
ander werkingsmechanisme heeft vergeleken met de antibiotica waar-
tegen deze organismen resistent zijn.
Bacillus subtilis werd gebruikt als model organisme om vast te stellen 
of verbinding 7b-BF4 de membraanpermeabiliteit van een organisme 
verstoord. Dit werd onderzocht met behulp van een combinatie van 
membraanpermeabele en membraanondoorlaatbare kleurstoffen (Res-
pectievelijk SYTO 9 en propidiumjodide). Verbinding 7b-BF4 bleek de 
membraanpermeabiliteit van B. subtilis niet te verstoren. Vervolgens 
werd bekeken of het membraanpotentiaal van B. subtilis wordt verstoord 
door verbinding 7b-BF4 met behulp van de potentiometrische probe 
DiSC3. Er is geen aanwijzing gevonden dat 7b-BF4 het membraanpo-
tentiaal verstoord in B. subtilis. Het effect van verbinding 7b-BF4 op de 
vier belangrijkste metabole routes (DNA, RNA, eiwit en peptidoglycaan 
synthese) werd getest in B. subtilis met behulp van 3H gelabelde meta-
bole precursors. 7b-BF4 beïnvloedde alle vier de routes zonder indicatie 
van een pathway-specifiek effect. 7b-BF4 veroorzaakt een sterke afname 
van de intracellulaire ATP-concentratie in B. subtilis, wat waarschijnlijk 
de reden is dat de vier metabole routes worden beïnvloed. Ontwikkeling 
van resistentie tegen 7b-BF4 werd gestimuleerd door in het lab groeien-

























karakterisering van de antimicrobiële activiteit van alkylgalaten tegen 
Xac (27).
Het laatste experimentele hoofdstuk van dit proefschrift (Hoofdstuk 4) 
richt zich op de celbiologie van Xac. In dit hoofdstuk ontwikkelden 
we een stam van Xac zonder het minC-gen Dit gen codeert voor het 
MinC-eiwit, onderdeel van het Min-systeem dat in Xac (evenals in 
de grondig bestudeerde bacterie Escherichia coli) bestaat uit de MinC-, 
MinD- en MinE-eiwitten (28). Dit systeem is verantwoordelijk voor de 
ruimtelijke regulatie van celdeling, ervoor zorgend dat dit gebeurt in 
het midden van de staafvormige cel en niet op een willekeurige plaats 
(bijvoorbeeld bij de celpolen). In E. coli is dit mogelijk omdat MinC een 
complex vormt met MinD, waardoor wordt voorkomen dat de Z-ring 
zich in de nabijheid daarvan assembleert. MinE-activiteit zorgt ervoor 
dat het MinCD-complex tussen de uiteinden van de cel oscilleert, met 
als gevolg dat de MinCD concentratie in het midden van de cel het laagst 
is en de Z-ring in het midden van de cel wordt gevormd (29).
We onderzochten celdeling, chromosoomsegregatie en incorporatie van 
peptidoglycaan in wild-type en ΔminC-mutanten. Het minC-gen werd 
verwijderd met behulp van allel-uitwisseling. Xac zonder het minC-gen 
vertoonde minicellen, korte filamentatie en vertakking. Het minC-gen 
werd gecomplementeerd door gfp-minC te integreren in de amy-locus. 
De gecomplementeerde Xac stammen vertoonden een wildtype feno-
type. Bovendien oscilleerde GFP-MinC van pool tot pool, vergelijkbaar 
met MinCD-oscillaties waargenomen in E.coli en meer recentelijk in 
Synechococcus elongatus (30) en Vibrio cholerae (31). Hierdoor lijkt os-
cillerend MinC gekoppeld te zijn aan aanwezigheid van het minE-gen. 
Verder onderzoek van het vertakkende fenotype onthulde dat in de 
vertakkingscellen de nucleoïdeorganisatie, de vorming van divisomen 
en de incorporatie van peptidoglycanen waren verstoord, en dat de 
synthese van peptidoglycaan was losgekoppeld van divisoomvorming 
in vertakte cellen. Het vertakkingsfenotype was ook voedingsstof af-
hankelijk en werd niet gezien in medium dat pepton bevatte.
Met dit proefschrift hebben we geprobeerd nieuwe mogelijkheden te 
openen voor het bestuderen van zowel de celbiologie van Xac als de 
Het effect van de verbindingen BC1 en T9A op de membraanpermeabili-
teit van Bacillus subtilis en Xac werd wederom getest met behulp van een 
combinatie van de membraanpermeabele en membraanondoorlaatbare 
kleurstoffen. Verbinding T9A verstoord de membraanpermeabiliteit 
niet in B. subtilis en Xac, terwijl verbinding BC1 B. subtilis-membra-
nen wel verstoort en Xac-membranen niet verstoort. Het effect van de 
verbindingen BC1 en T9A op vier belangrijke metabole routes (DNA, 
RNA-, eiwit- en peptidoglycan-synthese) in B. subtilis en Xac, waar-
bij dezelfde 3H gelabelde metabole precursors worden gebruikt. Dit 
hoofdstuk is, voor zover ons bekend, het eerste rapport van metabole 
route-assays op Xac. We hebben ook het effect van de verbindingen 
BC1 en T9A op de intracellulaire ATP-concentratie in B. subtilis en 
Xac getest. Vergelijkbaar met wat in hoofdstuk 2 werd waargenomen, 
hadden de chalconen invloed op alle vier de macromoleculaire meta-
bole routes. De ATP-concentratie werd echter niet beïnvloed door de 
verbindingen in B. subtilis en er werd weinig effect waargenomen in 
Xac. Fourier-transform infrarood (FT-IR) spectrofotometrie van met 
chalconen behandelde B. subtilis liet membraanverstoring zien door 
BC1, maar gaf geen doorslaggevend resultaat voor T9A. FT IR was niet 
succesvol in Xac omdat Xac xanthaangom bevat en biofilms maakt wat 
leidt tot een moeilijk te interpreteren FTIR spectrum. 
De gegevens die in dit hoofdstuk worden geproduceerd, laten ons niet 
toe een conclusie te trekken over een specifieke werkingswijze van de 
geteste verbindingen. We waren echter wel in staat om Xac-stammen 
te genereren met resistentie tegen de verbindingen T9A en BC1, wat 
de mogelijkheid opent om genomische sequentie analyses uit te voeren 
om de werkingswijze van deze verbindingen te achterhalen.
Dit hoofdstuk wordt gevolgd door een appendix waarin onze resulta-
ten van de werkingswijze van alkylgalaten tegen Xac worden vermeld. 
Alkylgalaten hebben activiteit tegen Xac, doden cellen in het laborato-
rium en voorkomen infectie op citrusbladeren (25). De antimicrobiële 
activiteit van alkylgalaten werd gekarakteriseerd in B. subtilis, omdat 
op dat moment FtsZ van Xac nog niet was gezuiverd en membraan-
permeabiliteitsassays nog niet ontwikkeld waren voor Xac (26). Deze 
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werkingswijze van antimicrobiële verbindingen. De radiolabelassays 
om specifieke metabole routes te testen, fluorescentieassays voor het 
testen van membraanpermeabiliteit, membraanpotentiaal en peptidog-
lycaan-opname, fluorescente eiwitfusies met ZapA-, MinC- en ParB- en 
FtsZ-assays die in dit proefschrift worden gebruikt, vormen een prima 
aanvulling op een gereedschapskist die is ingesteld op het testen van 
nieuwe antimicrobiële stoffen met de potentie voor de bestrijding van 
citruskanker en andere infecties. Genomische analyses van resistente 
mutanten en RNA-sequencing van cellen die zijn behandeld met an-
timicrobiele verbindingen zijn mogelijk nodig om onze toolset uit te 
breiden en om de werkingswijze van die antimicrobiële verbindingen 
in meer detail vast te stellen.
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